WO2017148426A1 - Method for determining fingerprint of chinese medicine composition - Google Patents

Method for determining fingerprint of chinese medicine composition Download PDF

Info

Publication number
WO2017148426A1
WO2017148426A1 PCT/CN2017/075513 CN2017075513W WO2017148426A1 WO 2017148426 A1 WO2017148426 A1 WO 2017148426A1 CN 2017075513 W CN2017075513 W CN 2017075513W WO 2017148426 A1 WO2017148426 A1 WO 2017148426A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
solution
methanol
preparation
weigh
Prior art date
Application number
PCT/CN2017/075513
Other languages
French (fr)
Chinese (zh)
Inventor
毕丹
陈育鹏
赵倩
叶玉廷
张水英
任晋
魏峰
Original Assignee
石家庄以岭药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 石家庄以岭药业股份有限公司 filed Critical 石家庄以岭药业股份有限公司
Publication of WO2017148426A1 publication Critical patent/WO2017148426A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography

Definitions

  • the invention relates to a method for determining a fingerprint of a traditional Chinese medicine composition.
  • the fingerprint of traditional Chinese medicine refers to the chromatogram or spectrum of some Chinese herbal medicines or traditional Chinese medicine preparations which have been subjected to proper analysis and can be marked with chemical characteristics.
  • the fingerprint of traditional Chinese medicine is a comprehensive and quantifiable method for identification. It is based on the study of the chemical composition system of traditional Chinese medicine, and is mainly used to evaluate the authenticity, superiority and stability of the quality of Chinese herbal medicines and semi-finished products of traditional Chinese medicine preparations. "Integrality” and "fuzziness" are distinctive features.
  • the use of fingerprints as a quality control method for extracts of traditional Chinese medicines (natural medicines) and their preparations has become an international consensus, and various fingerprint control technology systems that conform to the characteristics of traditional Chinese medicines (natural medicines) are being researched and established.
  • the US Food and Drug Administration allows chromatographic fingerprinting in herbal health product declarations; the World Health Organization (WHO) also provides guidelines for herbal evaluation in 1996 that provide chromatographic fingerprints if the active ingredients of the herbs are not clear.
  • WHO World Health Organization
  • the European Community also said in the herbal quality guidelines that it is not enough to determine the stability of an active ingredient alone, because the herbs and their preparations are active as a whole.
  • Chromatographic fingerprints especially the sharp fingerprints of thin-layer chromatography, are useful.
  • the application of foreign fingerprints aims to solve the problem of the quality of botanical drug detection and the difference in batch quality between products with complex composition and unclear active ingredients.
  • High-performance liquid chromatography (HPLC) fingerprint with high resolution which can separate complex chemical components to form different chromatograms.
  • the height and peak area of these peaks represent various Different chemical compositions and their contents. It can be seen that the fingerprint development of traditional Chinese medicine is further developed than the DNA fingerprinting: not only the characteristic manifestation (the number and relative position of various chemical components - retention time) can be used for qualitative identification, but also the concept of quantity. .
  • the height and peak area of the peak indicate the content of a certain chemical component, and the ratio of the peak height (or peak area) of each peak reflects the relative content of various chemical components; the introduction of the concept of quantity, the combination of qualitative and quantitative It can give greater effect to the fingerprint of traditional Chinese medicine; the fingerprint of traditional Chinese medicine can not only identify the “uniqueness” of individuals and certain species, but also link the characteristics of “quantity” with other systems. Therefore, the fingerprint of traditional Chinese medicine is not only a quality control mode and technology of traditional Chinese medicine, but also can be developed into a research system and research mode that uses various fingerprints to carry out traditional Chinese medicine theory (complex system) and new drug development. The fingerprint should be fingerprinted, ie: (1) strong.
  • the fingerprints developed should be unique to the traditional Chinese medicine and distinguish it from other traditional Chinese medicines.
  • the chemical information reflected is highly selective; (2) the stability is good. That is, the fingerprint of traditional Chinese medicine should be the commonality from multiple batches of a certain Chinese medicine, and the common peak or characteristic peak in the map should be relatively stable; (3) good reproducibility.
  • the fingerprints developed should be able to reproduce the fingerprint features (such as the number, size, location, etc. of the common peaks) under specified conditions, and the error should be within the allowable range. Only in this way can the fingerprints developed have practical value to effectively control the quality of the drugs.
  • the UPLC fingerprint method is used to control the quality of the drug. It is sensitive, rapid, simple and accurate.
  • the chromatographic conditions of the drug preparation can be used to determine the quality of the drug.
  • the fingerprint of traditional Chinese medicine can be used in various stages of research and production process of traditional Chinese medicine preparations. It can be divided into the fingerprints of traditional Chinese medicines (raw materials), the fingerprints of traditional Chinese medicines (including decoction pieces and compatible particles) and the fingerprints of traditional Chinese medicine preparations. . If it is finer, it can also include fingerprints for intermediates in the process production process. It is worth noting that the establishment of chemical fingerprints of Chinese herbal medicines must take into account the influence of many factors.
  • the variety of traditional Chinese medicines, the historically formed foreign bodies of the same name, the synonyms of the same name, and the fluctuation of the same species in the environment of the place of origin and the components contained in different effective parts have brought many problems to the quality control.
  • the patent application number is 201210450660.0, and the invention name is: a preparation process of an antiviral traditional Chinese medicine composition and a method for measuring a fingerprint, and a method for determining a fingerprint of an extract of forsythia, rhubarb, ephedra, and houttuynia by ultrasonic countercurrent extraction is disclosed. Twenty-seven shared peaks were identified, and four of the common peaks were identified, namely, forsythiaside A, forsythin, rosin-4-O-glc, and rhein. The application does not disclose the technical contents of the present invention.
  • the invention requires A method for determining a high performance liquid chromatographic fingerprint of a traditional Chinese medicine composition, which comprises: forsythia, honeysuckle, radix isatidis, bitter almond, menthol, houttuynia, rhubarb, patchouli, cotton Ma Guanzhong, Rhodiola, Ephedra, Licorice, Gypsum, the fingerprinting method, calibrated 15 major chromatographic peaks, identified 9 of them, respectively, new chlorogenic acid, chlorogenic acid, crypto-acid, different Forsythiaside A, forsythiaside A, forsythin, quercetin, 4,5-di-O-caffeoylquinic acid, forsythin, glycyrrhizic acid, and this is not disclosed in the prior art.
  • Technical content comprises: forsythia, honeysuckle, radix isatidis, bitter almond, menthol, houttuynia, rhubar
  • the invention provides a method for determining a fingerprint of a traditional Chinese medicine composition.
  • a method for determining a fingerprint of a traditional Chinese medicine composition the raw materials of the traditional Chinese medicine composition include: forsythia, ephedra, rhubarb, houttuynia, honeysuckle, radix isatidis, patchouli, Mianma Guanzhong, Rhodiola, menthol , bitter almond, licorice, gypsum; the fingerprinting method comprises the following steps:
  • test solution taking the traditional Chinese medicine composition, and extracting with an organic solvent to obtain a test solution;
  • reference solution fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoylquinine
  • the acid, quercetin, ammonium glycyrrhizinate reference substance is dissolved in an organic solvent to obtain a reference solution;
  • Preparation of the reference solution take appropriate amount of forsythiaside A reference substance, add organic solvent to dissolve, to obtain a reference solution;
  • Chromatographic conditions a methanol-acetonitrile-phosphoric acid aqueous solution as a mobile phase, gradient elution, the concentration of the aqueous phosphoric acid solution is 0.1% to 0.5%;
  • Determination method separately draw the reference solution and the test solution, inject into the liquid chromatograph, and measure, that is, obtain.
  • the organic solvent comprises 50% to 100% methanol solution, 50% to 100% ethanol solution; further preferably, the organic solvent is 50% methanol.
  • the gradient elution procedure is:
  • the detection wavelength is 200-250 nm.
  • the traditional Chinese medicine composition is prepared from the following raw materials by weight: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia 200-300, Honeysuckle 200-300, Ban GmbH 200-300, Patchouli 60-100, Mianma Guanzhong 200-300, Rhodiola 60-100, menthol 5-9, bitter almond 60-100, licorice 60-100, gypsum 200-300, fingerprinting method is as follows:
  • test solution Take 0.1-0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 40-100% methanol 10-50mL, weigh the weight, sonicate for 20-40 minutes , let cool, then weigh the weight, make up the lost weight with 40-100% methanol, shake, filter, take the filtrate, get it;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-coffee
  • the acyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml, respectively.
  • Forsythiaside A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g/ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column is a C 18 column; the detection wavelength is 239 nm, and the flow rate is 0.1-0.5 ml/min;
  • Determination method respectively, accurately draw the reference solution and the test solution each 1-10 ⁇ L, inject into the ultra-high liquid chromatograph, determine, record the chromatogram, that is.
  • the preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 200, Honeysuckle 300, Ban GmbH 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60, bitter almond 100, houttuynia cordica 200, licorice 100, gypsum 200.
  • the preferred parts of the traditional Chinese medicine composition of the present invention are: Forsythia 300, Honeysuckle 200, Ban GmbH 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100, bitter almond 60, houttuyniasis 300, licorice 60, gypsum 300.
  • the preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 278, Honeysuckle 294, Radix Isatidis 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88, bitter almond 80, houttuynia 284, licorice 95, gypsum 277.
  • the preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 255, Honeysuckle 255, Radix Isatidis 255, Rhubarb 51, Patchouli 85, Mianma Guanzhong 255, Rhodiola 85, Menthol 7.5, Ephedra 85, bitter almond 85, houttuynia 255, licorice 85, gypsum 255.
  • the preparation method of the traditional Chinese medicine composition preparation of the invention is:
  • the method for determining the fingerprint of the present invention is preferably:
  • test solution Take 0.25g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 50mL methanol 25mL, weigh the weight, sonication (power 500W, frequency 40kHz) for 30 minutes, Let cool, then weigh the weight, make up the lost weight with 50% methanol, shake it, filter it, take the filtrate, and get it;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was a Waters Acquity UPLC HSS T3 column with a column length of 100 mm, an inner diameter of 2.1 mm, a particle size of 1.8 ⁇ m, a detection wavelength of 239 nm, and a flow rate of 0.3 ml/min;
  • Assay method accurately draw 2 ⁇ L of each of the reference solution and the test solution, inject into an ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the fingerprint mapping method of the present invention is also preferably:
  • test solution Take 0.1g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, add 50mL of methanol precisely, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight, use Make up the lost weight of methanol, shake it, filter it, take the filtrate, and get it;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was a Waters Acquity UPLC HSS T3 column; the detection wavelength was 239 nm, and the flow rate was 0.1 ml/min;
  • Determination method respectively, accurately draw 1 ⁇ L of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the fingerprint mapping method of the present invention is also preferably:
  • test solution Take 0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 40mL methanol to 10mL, weigh the weight, sonicate for 20 minutes, let cool, then weigh the weight. , use 40% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was a column Waters XBridge TM Shield RP18; detection wavelength 239nm, flow rate 0.5ml / min;
  • Determination method respectively, accurately draw 1 ⁇ L of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the fingerprint mapping method of the present invention is also preferably:
  • test solution Take 0.2g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 20mL of methanol 20mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight , use 90% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was Phenomenex Kinetx XB-C18; the detection wavelength was 239 nm, and the flow rate was 0.4 ml/min;
  • Assay method accurately draw 6 ⁇ L of each of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • Example 1 Using the sample prepared in Example 1, the method for determining the fingerprint of the traditional Chinese medicine composition of the present invention was evaluated in various aspects, and the evaluation method was as follows:
  • the chromatograms of the test solutions at different detection wavelengths were examined at 210 nm to 400 nm, and the information amount at 239 nm was rich. Therefore, the detection wavelength was optimally selected to be 239 nm. For details, see the following Figures 1-4.
  • the ultrasonic and reflow methods were compared.
  • the number and intensity of the chromatographic peaks obtained by the ultrasonic and reflux extraction methods were not significantly different. For details, see Figure 12-13. Since the ultrasonic extraction method is simple, the ultrasound is selected. extract.
  • the reference solution and the test solution were injected separately, and 16 main chromatographic peaks were determined in the chromatogram of the test solution. According to the retention time and spectral characteristics of the chromatographic peak, it is determined that the peak of No. 2 in the fingerprint is new chlorogenic acid, the peak of No. 3 is chlorogenic acid, the peak of No. 5 is cryptochlorogenic acid, and the peak of No. 8 is isoprenoid A.
  • Peak 11 is forsythiaside A
  • peak 13 is quercetin
  • peak 14 is 4,5-di-O-caffeoylquinic acid
  • peak 15 is forsythin
  • peak 16 is glycyrrhizic acid.
  • test solution was taken and continuously injected 6 times according to the determined chromatographic conditions.
  • the RSD of each major peak area was less than 5%, indicating that the injection precision was good, and the results are shown in Table 2.
  • test solution was taken at 0h, 2h, 4h, 8h, 12h, 24h, and the RSD of each major peak area was less than 10%, indicating that the test solution was stable within 24h.
  • RSD of each major peak area was less than 10%, indicating that the test solution was stable within 24h.
  • Fingerprint establishment Take 10 batches of the sample of the traditional Chinese medicine composition of the invention, prepare the test solution according to the requirements of 3.4, and carry out the sample analysis under the above chromatographic conditions to obtain the fingerprints of 10 batches of the traditional Chinese medicine composition of the invention, and adopt The Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2004A version developed by the National Pharmacopoeia Committee analyzed the fingerprints of 10 batches of samples. The median method was used to correct and automatically match the chromatographic peaks of each fingerprint to calculate the similarity. A comparison fingerprint was generated, as shown in Figure 29-30. The similarity results are shown in Table 5.
  • the invention establishes a liquid phase fingerprinting method of the traditional Chinese medicine composition of the invention, which has 16 chromatographic peaks, and 9 common peaks are identified by standard products: new chlorogenic acid (peak No. 2) and chlorogenic acid (peak No. 3). , cryptochlorogenic acid (peak 5), forsythine A (peak 8), forsythiaside A (peak 11), quercetin (peak 13), 4,5-di-O - caffeoyl quinic acid (peak 14), forsythin (peak 15), glycyrrhizic acid (peak 16).
  • the 11th chromatographic peak forsythiaside A with a stable peak and a large peak area was used as a reference peak, and the similarity of the fingerprints of the 10 batches of the traditional Chinese medicine composition of the present invention was high. It can be seen from the above experimental results that the method has good precision and stability, and repeatability, and provides a new method for improving the quality control of the traditional Chinese medicine composition.
  • Figure 1 Chromatogram of the test solution at a detection wavelength of 320 nm
  • FIG. 12 Chromatogram of the sample solution for 30 minutes of ultrasound
  • Figure 20 Comparison of the spectrum of the new chlorogenic acid in the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
  • Figure 21 Comparison of the chlorogenic acid spectrum of the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
  • Figure 22 Comparison of the spectrum of the cryptochlorogenic acid in the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
  • Figure 23 Comparison of the reference solution of the reference solution with the testosterone A in the test solution, the dotted line is the spectrum of the test sample, and the solid line is the spectrum of the reference product.
  • Figure 24 Comparison of the reference solution of forsythiaside A in the reference solution and the test solution, the dotted line is the spectrum of the test sample, and the solid line is the spectrum of the reference product.
  • Figure 25 Comparison of the quercetin spectrum of the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
  • Figure 26 Comparison of the spectrum of 4,5-di-O-caffeoylquinic acid in the reference solution and the test solution.
  • the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
  • Figure 27 Comparison of the forsythiaside spectra of the reference solution and the test solution, the dotted line is the spectrum of the test sample, and the solid line is the reference spectrum of the reference product.
  • Figure 28 Comparison of the spectrum of glycyrrhizic acid in the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
  • Figure 33 Fingerprint of Example 3, wherein the peak 1 in Figure A is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid ester A, and 5 is forsythiaside A. 6 is quercetin, 7 is 4,5-di-O-caffeoylquinic acid, 8 is forsythin, 9 is glycyrrhizic acid; B is a chromatogram of forsythiaside A reference solution; C is Fingerprint chromatogram of test solution
  • Figure 34 Fingerprint of Example 4, wherein the peak 1 in Figure A is new chlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is berberine A, and 5 is forsythiaside A. 6 is quercetin, 7 is 4,5-di-O-caffeoylquinic acid, 8 is forsythin, 9 is glycyrrhizic acid; B is a chromatogram of forsythiaside A reference solution; C is Fingerprint chromatogram of test solution
  • test solution Take 0.25g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 50mL methanol 25mL, weigh the weight, ultrasonic power 500W, frequency 40kHz, ultrasonic 30 minutes, put Cold, weigh the weight again, make up the lost weight with 50% methanol, shake it, filter it, take the filtrate, and get it;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was a Waters Acquity UPLC HSS T3 column with a column length of 100 mm, an inner diameter of 2.1 mm, a particle size of 1.8 ⁇ m, a detection wavelength of 239 nm, and a flow rate of 0.3 ml/min;
  • Assay method accurately draw 2 ⁇ L of each of the reference solution and the test solution, inject into an ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • test solution Take 0.1g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 50mL of methanol, 50mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight. , use 100% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was a Waters Acquity UPLC HSS T3 (column length 100 mm, inner diameter 2.1 mm, particle size 1.8 ⁇ m) column; detection wavelength 239 nm, flow rate 0.1 ml / min;
  • Determination method respectively, accurately draw 1 ⁇ L of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the raw material formula is: 278g forsythia, 294g for honeysuckle, 285g for radix isatidis, 55g for rhubarb, 95g for patchouli, 290g for cotton horse, and 87g for Rhodiola Menthol 8.5g, ephedra 88g, bitter almond 80g, houttuynia 284g, licorice 95g, gypsum 277g, extracted according to the following process:
  • test solution Take 0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 40mL methanol to 10mL, weigh the weight, sonicate for 20 minutes, let cool, then weigh the weight. , use 40% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was Waters XBridge TM Shield RP18 (5 ⁇ m, 4.6mm ⁇ 250mm) column; detection wavelength 239nm, flow rate 0.5ml / min;
  • Determination method respectively, accurately draw 1 ⁇ L of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  • the raw material formula is: weighed according to the ratio: Forsythia 255g, Honeysuckle 255g, Radix Isatidis 255g, Rhubarb 51g, Patchouli 85g, Mianma Guanzhong 255g, Rhodiola 85g, Menthol 7.5g, Ephedra 85g, Bitter Almond 85g Houttuynia 255g, licorice 85g, gypsum 255g, extracted according to the following process:
  • test solution Take 0.2g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 20mL of methanol 20mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight , use 90% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
  • Preparation of reference solution weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl
  • the appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 ⁇ g/ml neochlorogenic acid, 27.2 ⁇ g/ml chlorogenic acid, 21.2 ⁇ g/ml cryptochlorogenic acid, and 27.2 ⁇ g/ml.
  • Ester A 21.6 ⁇ g/ml forsythiaside A, 16.0 ⁇ g/ml forsythin, 14.4 ⁇ g/ml 4,5-di-O-caffeoylquinic acid, 9.0 ⁇ g/ml quercetin, 24.4 ⁇ g /ml ammonium glycyrrhizinate mixed control solution is obtained;
  • Preparation of the reference solution Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 ⁇ g per 1 ml, that is.
  • the column was a Phenomenex Kinetx XB-C18 column; the detection wavelength was 239 nm, and the flow rate was 0.4 ml/min;
  • Assay method accurately draw 6 ⁇ L of each of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.

Abstract

Provided is a method for determining a high-performance liquid chromatographic fingerprint of a Chinese medicine composition. The Chinese medicine composition consists of forsythia, Japanese honeysuckle, indigowoad root, bitter almond, mentha-camphor, houttuynia cordata, rhubarb, patchouli, male fern rhizome, kirilow rhodiola root and rhizome, ephedra, licorice, and gypsum. The fingerprint determination method detects 15 main chromatographic peaks, and identifies nine of the main chromatographic peaks as neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isoforsythiaside A, forsythiaside A, forsythin, quercitrin, 4,5-di-O-caffeoylquinic acid, and glycyrrhizic acid ammonium salt, respectively.

Description

一种中药组合物的指纹图谱的测定方法Method for determining fingerprint of traditional Chinese medicine composition 技术领域Technical field
本发明涉及到一种中药组合物的指纹图谱的测定方法。The invention relates to a method for determining a fingerprint of a traditional Chinese medicine composition.
背景技术Background technique
中药指纹图谱是指某些中药材或中药制剂经适当处理后,采用一定的分析手段,得到的能够标示其化学特征的色谱图或光谱图。中药指纹图谱是一种综合的,可量化的鉴定手段,它是建立在中药化学成分系统研究的基础上,主要用于评价中药材以及中药制剂半成品质量的真实性、优良性和稳定性。“整体性”和“模糊性”为其显著特点。以指纹图谱作为中药(天然药物)提取物及其制剂的质量控制方法,已成为目前国际共识,各种符合中药(天然药物)特色的指纹图谱控制技术体系正在研究和建立。美国食品药品管理局(FDA)允许草药保健品申报资料中提供色谱指纹图谱;世界卫生组织(WHO)在1996年草药评价指导原则中也规定,如果草药的活性成分不明确,可以提供色谱指纹图谱以证明产品质量的一致;欧共体在草药质量指南中亦称,单靠测定某种有效成分考查质量的稳定性是不够的,因为草药及其制剂是以整体为活性物质。色谱指纹图谱尤其是薄层色谱的鲜明的指纹图谱是很有用的。国外指纹图谱的应用,目的在于解决成分复杂,有效成分不明确的植物药质量检测和产品批次间质量差异的问题。The fingerprint of traditional Chinese medicine refers to the chromatogram or spectrum of some Chinese herbal medicines or traditional Chinese medicine preparations which have been subjected to proper analysis and can be marked with chemical characteristics. The fingerprint of traditional Chinese medicine is a comprehensive and quantifiable method for identification. It is based on the study of the chemical composition system of traditional Chinese medicine, and is mainly used to evaluate the authenticity, superiority and stability of the quality of Chinese herbal medicines and semi-finished products of traditional Chinese medicine preparations. "Integrality" and "fuzziness" are distinctive features. The use of fingerprints as a quality control method for extracts of traditional Chinese medicines (natural medicines) and their preparations has become an international consensus, and various fingerprint control technology systems that conform to the characteristics of traditional Chinese medicines (natural medicines) are being researched and established. The US Food and Drug Administration (FDA) allows chromatographic fingerprinting in herbal health product declarations; the World Health Organization (WHO) also provides guidelines for herbal evaluation in 1996 that provide chromatographic fingerprints if the active ingredients of the herbs are not clear. To prove the consistency of product quality; the European Community also said in the herbal quality guidelines that it is not enough to determine the stability of an active ingredient alone, because the herbs and their preparations are active as a whole. Chromatographic fingerprints, especially the sharp fingerprints of thin-layer chromatography, are useful. The application of foreign fingerprints aims to solve the problem of the quality of botanical drug detection and the difference in batch quality between products with complex composition and unclear active ingredients.
高效液相色谱(HPLC)指纹图谱,具有很高的分离度,可把复杂的化学成分进行分离而形成高低不同的峰组成一张色谱图,这些色谱峰的高度和峰面积分别代表了各种不同化学成分和其含量。由此可见,中药指纹图谱比DNA指纹图谱更进一步的发展在于:不但有特征的体现(各种化学成分的个数和相对位置——保留时间)可作定性鉴别使用,还体现了量的概念。峰的高度和峰面积表示了某个化学成分的含量,而各峰的峰高(或峰面积)的比值体现了各种化学成分间的相对含量;量的概念的引入、定性和定量的结合赋予中药指纹图谱更大的功效;中药指纹图谱不仅可以进行个体、某物种的“唯一性”的鉴定,还可以将其“量”的特征和其他体系挂钩。因此,中药指纹图谱不仅是一种中药质量控制模式和技术,更可以发展成为一种采用各种指纹图谱来进行中药理论(复杂系统)和新药开发的研究体系和研究模式。指纹图谱应该具备指纹性,即:(1)专属性强。指所制订的指纹图谱应该是该中药所独有的、能与其它中药相区别的,其反映的化学信息是具有高度的选择性的;(2)稳定性好。即中药的指纹图谱应该是从某中药的多批次中归纳出的共性,图谱中的共有峰或特征峰应相对稳定;(3)重现性好。所制订的指纹图谱在规定条件下应能再现指纹特征(如共有峰数目、大小、位置等),其误差应在允许的范围内。只有这样,所制订的指纹图谱才具有实用价值,才可以有效控制药品的质量。采用UPLC指纹图谱方法控制药品质量具有灵敏、快速、简便、准确等特点,通过优选色谱条件测定药品制剂的指纹图谱,可以很好控制药品质量。High-performance liquid chromatography (HPLC) fingerprint with high resolution, which can separate complex chemical components to form different chromatograms. The height and peak area of these peaks represent various Different chemical compositions and their contents. It can be seen that the fingerprint development of traditional Chinese medicine is further developed than the DNA fingerprinting: not only the characteristic manifestation (the number and relative position of various chemical components - retention time) can be used for qualitative identification, but also the concept of quantity. . The height and peak area of the peak indicate the content of a certain chemical component, and the ratio of the peak height (or peak area) of each peak reflects the relative content of various chemical components; the introduction of the concept of quantity, the combination of qualitative and quantitative It can give greater effect to the fingerprint of traditional Chinese medicine; the fingerprint of traditional Chinese medicine can not only identify the “uniqueness” of individuals and certain species, but also link the characteristics of “quantity” with other systems. Therefore, the fingerprint of traditional Chinese medicine is not only a quality control mode and technology of traditional Chinese medicine, but also can be developed into a research system and research mode that uses various fingerprints to carry out traditional Chinese medicine theory (complex system) and new drug development. The fingerprint should be fingerprinted, ie: (1) strong. It means that the fingerprints developed should be unique to the traditional Chinese medicine and distinguish it from other traditional Chinese medicines. The chemical information reflected is highly selective; (2) the stability is good. That is, the fingerprint of traditional Chinese medicine should be the commonality from multiple batches of a certain Chinese medicine, and the common peak or characteristic peak in the map should be relatively stable; (3) good reproducibility. The fingerprints developed should be able to reproduce the fingerprint features (such as the number, size, location, etc. of the common peaks) under specified conditions, and the error should be within the allowable range. Only in this way can the fingerprints developed have practical value to effectively control the quality of the drugs. The UPLC fingerprint method is used to control the quality of the drug. It is sensitive, rapid, simple and accurate. The chromatographic conditions of the drug preparation can be used to determine the quality of the drug.
中药指纹图谱可用于中药制剂研究、生产过程的各个阶段,按应用对象来分类,可分为中药材(原料药材)指纹图谱、中药原料药(包括饮片、配伍颗粒)指纹图谱和中药制剂指纹图谱。如分得更细,还可包括用于工艺生产过程中间产物的指纹图谱。值得注意的是建立中药材化学指纹图谱必须考虑诸多因素的影响。中药品种混杂,历史上形成的同名异物、异名同物,以及同一物种受产地环境、不同有效部位所含成分的波动大等因素,给质量控制带来了很多困扰。因此对于某一种中药材的指纹图谱,需要有大量的数据积累,才能制定合理的相似性标准。中药及其制剂均为多组分复杂体系,因此评价其质量应采用与之相适应的,能提供丰富鉴别信息的检测方法,但现行的显微鉴别、理化鉴别和含量测定等方法都不足以解决这一问题,建立中药指纹图谱将能较为全面地反映中药及其制剂中所含化学成分的种类与数量,进而对药品质量进行整体描述和评价。这也正好符合中医药整体学说。在此基础上,如果进一步开展谱效学研究,可使中药质量与其药效真正结合起来,有助于阐明中药作用机理。总之,中药指纹图谱的研究和建立,对于提高中药质量,促进中药现代化具有重要意义。The fingerprint of traditional Chinese medicine can be used in various stages of research and production process of traditional Chinese medicine preparations. It can be divided into the fingerprints of traditional Chinese medicines (raw materials), the fingerprints of traditional Chinese medicines (including decoction pieces and compatible particles) and the fingerprints of traditional Chinese medicine preparations. . If it is finer, it can also include fingerprints for intermediates in the process production process. It is worth noting that the establishment of chemical fingerprints of Chinese herbal medicines must take into account the influence of many factors. The variety of traditional Chinese medicines, the historically formed foreign bodies of the same name, the synonyms of the same name, and the fluctuation of the same species in the environment of the place of origin and the components contained in different effective parts have brought many problems to the quality control. Therefore, for a fingerprint of a certain Chinese herbal medicine, a large amount of data accumulation is required to establish a reasonable similarity standard. Traditional Chinese medicines and their preparations are multi-component complex systems. Therefore, the quality should be evaluated according to their suitability. It can provide a wealth of identification information, but the current methods of microscopic identification, physical and chemical identification and content determination are not enough. To solve this problem, the establishment of traditional Chinese medicine fingerprints will be able to more comprehensively reflect the types and quantities of chemical components contained in traditional Chinese medicines and their preparations, and then describe and evaluate the quality of medicines as a whole. This is also in line with the overall theory of Chinese medicine. On this basis, if the spectral effect study is further carried out, the quality of traditional Chinese medicine and its efficacy can be truly combined, which helps to elucidate the mechanism of action of traditional Chinese medicine. In short, the research and establishment of the fingerprint of traditional Chinese medicine is of great significance for improving the quality of traditional Chinese medicine and promoting the modernization of traditional Chinese medicine.
专利申请号为201210450660.0,发明名称为:一种抗病毒中药组合物的制备工艺及指纹图谱的测定方法,公开了连翘、大黄、麻黄、鱼腥草超声逆流提取的提取液的指纹图谱测定方法,标定了27个共有峰,指认了其中4个共有峰,分别为连翘酯苷A、连翘苷、松脂素-4-O-glc、大黄酸,该申请没有公开本发明的技术内容。本发明要 求保护一种中药组合物的高效液相色谱指纹图谱测定方法,该中药组合物由以下药材组成:连翘、金银花、板蓝根、苦杏仁、薄荷脑、鱼腥草、大黄、广藿香、绵马贯众、红景天、麻黄、甘草、石膏,该指纹图谱测定方法,标定了15个主要色谱峰,指认了其中9个,分别为新绿原酸,绿原酸,隐绿原酸,异连翘酯苷A,连翘酯苷A,连翘苷,槲皮苷,4,5-二-O-咖啡酰奎宁酸,连翘苷,甘草酸,而现有技术中并没有公开该技术内容。The patent application number is 201210450660.0, and the invention name is: a preparation process of an antiviral traditional Chinese medicine composition and a method for measuring a fingerprint, and a method for determining a fingerprint of an extract of forsythia, rhubarb, ephedra, and houttuynia by ultrasonic countercurrent extraction is disclosed. Twenty-seven shared peaks were identified, and four of the common peaks were identified, namely, forsythiaside A, forsythin, rosin-4-O-glc, and rhein. The application does not disclose the technical contents of the present invention. The invention requires A method for determining a high performance liquid chromatographic fingerprint of a traditional Chinese medicine composition, which comprises: forsythia, honeysuckle, radix isatidis, bitter almond, menthol, houttuynia, rhubarb, patchouli, cotton Ma Guanzhong, Rhodiola, Ephedra, Licorice, Gypsum, the fingerprinting method, calibrated 15 major chromatographic peaks, identified 9 of them, respectively, new chlorogenic acid, chlorogenic acid, crypto-acid, different Forsythiaside A, forsythiaside A, forsythin, quercetin, 4,5-di-O-caffeoylquinic acid, forsythin, glycyrrhizic acid, and this is not disclosed in the prior art. Technical content.
发明内容Summary of the invention
本发明提供一种中药组合物的指纹图谱测定方法。The invention provides a method for determining a fingerprint of a traditional Chinese medicine composition.
一种中药组合物的指纹图谱测定方法,该中药组合物的原料药包括:连翘、麻黄、大黄、鱼腥草、金银花、板蓝根、广藿香、绵马贯众、红景天、薄荷脑、苦杏仁、甘草、石膏;所述指纹图谱测定方法包括如下步骤:A method for determining a fingerprint of a traditional Chinese medicine composition, the raw materials of the traditional Chinese medicine composition include: forsythia, ephedra, rhubarb, houttuynia, honeysuckle, radix isatidis, patchouli, Mianma Guanzhong, Rhodiola, menthol , bitter almond, licorice, gypsum; the fingerprinting method comprises the following steps:
供试品溶液制备:取中药组合物,加有机溶剂提取,得供试品溶液;Preparation of the test solution: taking the traditional Chinese medicine composition, and extracting with an organic solvent to obtain a test solution;
对照品溶液的制备:分别取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,加有机溶剂溶解,得对照品溶液;Preparation of reference solution: fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoylquinine The acid, quercetin, ammonium glycyrrhizinate reference substance is dissolved in an organic solvent to obtain a reference solution;
参照物溶液的制备:取连翘酯苷A对照品适量,加有机溶剂溶解,得参照物溶液;Preparation of the reference solution: take appropriate amount of forsythiaside A reference substance, add organic solvent to dissolve, to obtain a reference solution;
色谱条件:以甲醇-乙腈-磷酸水溶液为流动相,梯度洗脱,所述磷酸水溶液浓度为0.1%~0.5%;Chromatographic conditions: a methanol-acetonitrile-phosphoric acid aqueous solution as a mobile phase, gradient elution, the concentration of the aqueous phosphoric acid solution is 0.1% to 0.5%;
测定法:分别吸取对照品溶液与供试品溶液,注入液相色谱仪,测定,即得。Determination method: separately draw the reference solution and the test solution, inject into the liquid chromatograph, and measure, that is, obtain.
优选的,所述有机溶剂包括50%~100%的甲醇溶液、50%~100%的乙醇溶液;进一步优选的,所述有机溶剂为50%甲醇。Preferably, the organic solvent comprises 50% to 100% methanol solution, 50% to 100% ethanol solution; further preferably, the organic solvent is 50% methanol.
优选的,所述梯度洗脱程序为:Preferably, the gradient elution procedure is:
Figure PCTCN2017075513-appb-000001
Figure PCTCN2017075513-appb-000001
优选的,所述检测波长为200-250nm。Preferably, the detection wavelength is 200-250 nm.
优选的,该中药组合物由如下重量份的原料药制成:连翘200-300、麻黄60-100、大黄40-60、鱼腥草200-300、金银花200-300、板蓝根200-300、广藿香60-100、绵马贯众200-300、红景天60-100、薄荷脑5-9、苦杏仁60-100、甘草60-100、石膏200-300,指纹图谱测定方法如下:Preferably, the traditional Chinese medicine composition is prepared from the following raw materials by weight: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia 200-300, Honeysuckle 200-300, Banlangen 200-300, Patchouli 60-100, Mianma Guanzhong 200-300, Rhodiola 60-100, menthol 5-9, bitter almond 60-100, licorice 60-100, gypsum 200-300, fingerprinting method is as follows:
供试品溶液制备:取所述中药组合物0.1-0.5g,精密称定,置具塞锥形瓶中,精密加入40-100%甲醇10-50mL,称定重量,超声处理20-40分钟,放冷,再称定重量,用40-100%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.1-0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 40-100% methanol 10-50mL, weigh the weight, sonicate for 20-40 minutes , let cool, then weigh the weight, make up the lost weight with 40-100% methanol, shake, filter, take the filtrate, get it;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡 酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-coffee The acyl quinic acid, quercetin, ammonium glycyrrhizinate reference substance was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml, respectively. Forsythiaside A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4μg/ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000002
Figure PCTCN2017075513-appb-000002
色谱柱为C18色谱柱;检测波长239nm,流速0.1-0.5ml/min;The column is a C 18 column; the detection wavelength is 239 nm, and the flow rate is 0.1-0.5 ml/min;
测定法:分别精密吸取对照品溶液与供试品溶液各1-10μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw the reference solution and the test solution each 1-10μL, inject into the ultra-high liquid chromatograph, determine, record the chromatogram, that is.
本发明所述的中药组合物优选的重量份原料药为:连翘200、金银花300、板蓝根200、大黄40、广藿香60、绵马贯众300、红景天100、薄荷脑9、麻黄60、苦杏仁100、鱼腥草200、甘草100、石膏200。The preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 200, Honeysuckle 300, Banlangen 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60, bitter almond 100, houttuynia cordica 200, licorice 100, gypsum 200.
本发明所述的中药组合物优选的重量份原料药为:连翘300、金银花200、板蓝根300、大黄60、广藿香100、绵马贯众200、红景天60、薄荷脑5、麻黄100、苦杏仁60、鱼腥草300、甘草60、石膏300。The preferred parts of the traditional Chinese medicine composition of the present invention are: Forsythia 300, Honeysuckle 200, Banlangen 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100, bitter almond 60, houttuyniasis 300, licorice 60, gypsum 300.
本发明所述的中药组合物优选的重量份原料药为:连翘278、金银花294、板蓝根285、大黄55、广藿香95、绵马贯众290、红景天87、薄荷脑8.5、麻黄88、苦杏仁80、鱼腥草284、甘草95、石膏277。The preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 278, Honeysuckle 294, Radix Isatidis 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88, bitter almond 80, houttuynia 284, licorice 95, gypsum 277.
本发明所述的中药组合物优选的重量份原料药为:连翘255、金银花255、板蓝根255、大黄51、广藿香85、绵马贯众255、红景天85、薄荷脑7.5、麻黄85、苦杏仁85、鱼腥草255、甘草85、石膏255。The preferred pharmaceutical ingredients of the traditional Chinese medicine composition of the present invention are: Forsythia 255, Honeysuckle 255, Radix Isatidis 255, Rhubarb 51, Patchouli 85, Mianma Guanzhong 255, Rhodiola 85, Menthol 7.5, Ephedra 85, bitter almond 85, houttuynia 255, licorice 85, gypsum 255.
本发明所述的中药组合物制剂的制备方法为:The preparation method of the traditional Chinese medicine composition preparation of the invention is:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用; (5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,密闭,混匀,压片或者装胶囊、或者装袋。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, sealed, mixed, tableted or capsuled, or bagged.
本发明所述指纹图谱测定方法优选为:The method for determining the fingerprint of the present invention is preferably:
供试品溶液制备:取所述中药组合物0.25g,精密称定,置具塞锥形瓶中,精密加入50%甲醇25mL,称定重量,超声处理(功率500W,频率40kHz)30分钟,放冷,再称定重量,用50%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.25g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 50mL methanol 25mL, weigh the weight, sonication (power 500W, frequency 40kHz) for 30 minutes, Let cool, then weigh the weight, make up the lost weight with 50% methanol, shake it, filter it, take the filtrate, and get it;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000003
Figure PCTCN2017075513-appb-000003
色谱柱为Waters Acquity UPLC HSS T3色谱柱,柱长为100mm,内径为2.1mm,粒径为1.8μm;检测波长239nm,流速0.3ml/min;The column was a Waters Acquity UPLC HSS T3 column with a column length of 100 mm, an inner diameter of 2.1 mm, a particle size of 1.8 μm, a detection wavelength of 239 nm, and a flow rate of 0.3 ml/min;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入超高液相色谱仪,测定,记录色谱图,即得。Assay method: accurately draw 2 μL of each of the reference solution and the test solution, inject into an ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述指纹图谱测定方法还优选为:The fingerprint mapping method of the present invention is also preferably:
供试品溶液制备:取所述中药组合物0.1g,精密称定,置具塞锥形瓶中,精密加入甲醇50mL,称定重量,超声处理40分钟,放冷,再称定重量,用甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.1g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, add 50mL of methanol precisely, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight, use Make up the lost weight of methanol, shake it, filter it, take the filtrate, and get it;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为: Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000004
Figure PCTCN2017075513-appb-000004
色谱柱为Waters Acquity UPLC HSS T3色谱柱;检测波长239nm,流速0.1ml/min;The column was a Waters Acquity UPLC HSS T3 column; the detection wavelength was 239 nm, and the flow rate was 0.1 ml/min;
测定法:分别精密吸取对照品溶液与供试品溶液各1μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 1 μL of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述指纹图谱测定方法还优选为:The fingerprint mapping method of the present invention is also preferably:
供试品溶液制备:取所述中药组合物0.5g,精密称定,置具塞锥形瓶中,精密加入40%甲醇10mL,称定重量,超声处理20分钟,放冷,再称定重量,用40%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 40mL methanol to 10mL, weigh the weight, sonicate for 20 minutes, let cool, then weigh the weight. , use 40% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000005
Figure PCTCN2017075513-appb-000005
色谱柱为Waters XBridgeTM Shield RP18色谱柱;检测波长239nm,流速0.5ml/min; The column was a column Waters XBridge TM Shield RP18; detection wavelength 239nm, flow rate 0.5ml / min;
测定法:分别精密吸取对照品溶液与供试品溶液各1μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 1 μL of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
本发明所述指纹图谱测定方法还优选为:The fingerprint mapping method of the present invention is also preferably:
供试品溶液制备:取所述中药组合物0.2g,精密称定,置具塞锥形瓶中,精密加入90%甲醇20mL,称定重量,超声处理40分钟,放冷,再称定重量,用90%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.2g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 20mL of methanol 20mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight , use 90% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000006
Figure PCTCN2017075513-appb-000006
色谱柱为Phenomenex Kinetx XB-C18;检测波长239nm,流速0.4ml/min;The column was Phenomenex Kinetx XB-C18; the detection wavelength was 239 nm, and the flow rate was 0.4 ml/min;
测定法:分别精密吸取对照品溶液与供试品溶液各6μL,注入超高液相色谱仪,测定,记录色谱图,即得。Assay method: accurately draw 6 μL of each of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
用实施例1制备的样品,对本发明中药组合物的指纹图谱测定方法,从多个方面评价其可行性,评价方法如下:Using the sample prepared in Example 1, the method for determining the fingerprint of the traditional Chinese medicine composition of the present invention was evaluated in various aspects, and the evaluation method was as follows:
1.仪器、试剂与试药1. Instruments, reagents and reagents
1.1仪器1.1 Instrument
美国Waters UPLC H-CLASS超高效液相色谱仪(PDA检测器,Empower 3.0色谱工作站),循环式多用真空泵(郑州长城科工贸有限公司),KQ250DB型超声波清洗器(昆山市超声仪器有限公司),瑞士METTLER TOLEDOAL204型电子分析天平,瑞士METTLERTOLEDOAB135-S型电子分析天平,上海精科JA2603B电子天平。American Waters UPLC H-CLASS Ultra High Performance Liquid Chromatograph (PDA detector, Empower 3.0 chromatography workstation), circulating multi-purpose vacuum pump (Zhengzhou Changcheng Branch Industry and Trade Co., Ltd.), KQ250DB ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.) , Switzerland METTLER TOLEDOAL204 electronic analytical balance, Switzerland METTLERTOLEDOAB135-S electronic analytical balance, Shanghai Jingke JA2603B electronic balance.
1.2试剂1.2 reagent
连翘苷(中国食品药品检定研究院,批号110821-201213,纯度95.3%),连翘酯苷A(中国食品药品检定研究院,批号111810-201304,纯度94.3%),新绿原酸(成都普瑞法科技开发有限公司,批号:13112712,纯度≥98%),绿原酸(中国食品药品检定研究院,批号:110753-201314,纯度,96.6%),隐绿原酸(上海源叶生物科技有限公司,批号:ZF0226BA14,纯度≥98%),异连翘酯苷A(上海源叶生物科技有限公司,批号:YA0817HB14,纯度≥98%)、4,5-二-O-咖啡酰奎宁酸(中国食品药品检定研究院,批号:111894-201102,纯度,94.1%),槲皮苷(HWI ANALYTIK GMBH pharma solutions,批号:HWI01112,纯度,91.7%),甘草酸铵(Council ofEurope-EDQM,批 号:Batch:1.1,纯度≥98%),甲醇(分析纯,天津市光复科技发展有限公司,批号2014年1月13日),磷酸(分析纯,天津市光复科技发展有限公司,批号2014年3月26日),乙腈(色谱纯,美国Fisher公司,LOT 106246)。Forsythin (China Food and Drug Control Institute, batch number 110821-201213, purity 95.3%), forsythiaside A (China Food and Drug Control Institute, batch number 111810-201304, purity 94.3%), new chlorogenic acid (Chengdupu Ruifa Technology Development Co., Ltd., batch number: 13112712, purity ≥98%), chlorogenic acid (China Food and Drug Control Institute, batch number: 110753-201314, purity, 96.6%), cryptochlorogenic acid (Shanghai Yuanye Biotechnology) Co., Ltd., batch number: ZF0226BA14, purity ≥98%), isophoric acid ester A (Shanghai Yuanye Biotechnology Co., Ltd., batch number: YA0817HB14, purity ≥98%), 4,5-di-O-caffeoylquinine Acid (China Food and Drug Control Institute, batch number: 111894-201102, purity, 94.1%), saponin (HWI ANALYTIK GMBH pharma solutions, batch number: HWI01112, purity, 91.7%), ammonium glycinate (Council of Europe-EDQM, Batch No.: Batch: 1.1, purity ≥98%), methanol (analytical grade, Tianjin Guangfu Technology Development Co., Ltd., batch number January 13, 2014), phosphoric acid (analytical grade, Tianjin Guangfu Technology Development Co., Ltd., batch number 2014 March 26), acetonitrile (chromatographically pure, Fisher, USA, LOT 106246).
1.3试药1.3 test drugs
本发明中药组合物(石家庄以岭药业股份有限公司)Traditional Chinese medicine composition of the invention (Shijiazhuang Yiling Pharmaceutical Co., Ltd.)
2.色谱条件优化2. Optimization of chromatographic conditions
2.1.检测波长的选择2.1. Selection of detection wavelength
在210nm~400nm考察供试品溶液不同检测波长下的色谱图,以239nm下的信息量较丰富,因此检测波长最优选择239nm,具体信息见下附图1-4。The chromatograms of the test solutions at different detection wavelengths were examined at 210 nm to 400 nm, and the information amount at 239 nm was rich. Therefore, the detection wavelength was optimally selected to be 239 nm. For details, see the following Figures 1-4.
2.2流动相系统的选择2.2 Selection of mobile phase system
本研究比较了甲醇-0.1%磷酸、乙腈-0.1%磷酸和甲醇-乙腈-0.1%磷酸三个流动相系统。结果显示甲醇-乙腈-0.1%磷酸系统色谱峰的分离度最好,具体信息见附图5-7,因此,确定流动相系统为甲醇-乙腈-0.1%磷酸,梯度洗脱表见表1,流速0.3ml/min。This study compared three mobile phase systems of methanol-0.1% phosphoric acid, acetonitrile-0.1% phosphoric acid and methanol-acetonitrile-0.1% phosphoric acid. The results showed that the resolution of the methanol-acetonitrile-0.1% phosphoric acid system peak was the best. See Figure 5-7 for details. Therefore, the mobile phase system was determined to be methanol-acetonitrile-0.1% phosphoric acid. The gradient elution table is shown in Table 1. The flow rate was 0.3 ml/min.
表1  流动相梯度洗脱表Table 1 Mobile phase gradient elution table
Figure PCTCN2017075513-appb-000007
Figure PCTCN2017075513-appb-000007
3.供试品溶液和对照品溶液的制备3. Preparation of test solution and reference solution
3.1提取溶剂的考察3.1 Investigation of extraction solvent
分别比较了甲醇,90%甲醇,70%甲醇,50%甲醇的提取效果,结果表明50%甲醇提取所得指纹图谱中色谱峰最多,具体信息见附图8-11,因此选择50%甲醇作为提取溶剂。The extraction results of methanol, 90% methanol, 70% methanol and 50% methanol were compared. The results showed that the chromatographic peaks of the fingerprints obtained by 50% methanol extraction were the most. See Figure 8-11 for details. Therefore, 50% methanol was selected as the extraction. Solvent.
3.2提取方法的考察3.2 Investigation of extraction methods
分别比较了超声和回流两种提取方法,超声和回流提取两种方法所得的指纹图谱色谱峰的数目和强度没有明显区别,具体信息见附图12-13,由于超声提取方法简便,因此选择超声提取。The ultrasonic and reflow methods were compared. The number and intensity of the chromatographic peaks obtained by the ultrasonic and reflux extraction methods were not significantly different. For details, see Figure 12-13. Since the ultrasonic extraction method is simple, the ultrasound is selected. extract.
3.3超声时间的考察3.3 Ultrasonic time investigation
分别比较了超声20分钟、30分钟、40分钟,结果表明超声30分钟与40分钟所得指纹图谱中色谱峰信息量大,无明显区别,具体信息见附图14-16,因此最终确定超声时间为30分钟。Ultrasound was compared for 20 minutes, 30 minutes, and 40 minutes. The results showed that the amount of peak information in the fingerprints obtained by ultrasound for 30 minutes and 40 minutes was large, and there was no significant difference. For details, see Figure 14-16. 30 minutes.
3.4供试品溶液制备方法的确定:取本发明中药组合物内容物适量,研细,取0.25g,精密称定,置具塞锥形瓶中,精密加入50%甲醇25mL,称定重量,超声处理(功率500W,频率40kHz)30分钟,放冷,再称定重量,用 50%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得。3.4 Determination of the preparation method of the test solution: Take the appropriate amount of the content of the traditional Chinese medicine composition of the invention, grind finely, take 0.25g, accurately weigh, place in a conical flask, precisely add 50mL methanol 25mL, weigh the weight, Ultrasonic treatment (power 500W, frequency 40kHz) for 30 minutes, let cool, then weigh the weight, use 50% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain.
3.5对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得。3.5 Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeyl Quinine, quercetin, ammonium glycyrrhizinate reference substance, respectively, made of 18.4μg / ml new chlorogenic acid, 27.2μg / ml chlorogenic acid, 21.2μg / ml cryptochlorogenic acid, 27.2μg / ml Phytosterol A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 Μg/ml ammonium glycyrrhizinate mixed control solution is obtained.
3.6参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。3.6 Preparation of reference solution: Take appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make 101.2μg solution per 1ml, that is.
主要色谱峰的光谱特征和辨认在已确定的色谱条件下,分别对对照品溶液和供试品溶液进样,供试品溶液的色谱图中确定16个主要色谱峰。根据色谱峰的保留时间和光谱特征,确定指纹图谱中2号峰为新绿原酸,3号峰为绿原酸,5号峰为隐绿原酸,8号峰为异连翘酯苷A,11号峰为连翘酯苷A,13号峰为槲皮苷,14号峰为4,5-二-O-咖啡酰奎宁酸,15号峰为连翘苷,16号峰为甘草酸,以上对照品与供试品色谱图及光谱图见附图17-28。Spectral characteristics and identification of the main chromatographic peaks Under the determined chromatographic conditions, the reference solution and the test solution were injected separately, and 16 main chromatographic peaks were determined in the chromatogram of the test solution. According to the retention time and spectral characteristics of the chromatographic peak, it is determined that the peak of No. 2 in the fingerprint is new chlorogenic acid, the peak of No. 3 is chlorogenic acid, the peak of No. 5 is cryptochlorogenic acid, and the peak of No. 8 is isoprenoid A. Peak 11 is forsythiaside A, peak 13 is quercetin, peak 14 is 4,5-di-O-caffeoylquinic acid, peak 15 is forsythin, and peak 16 is glycyrrhizic acid. The chromatograms and spectra of the above reference and test samples are shown in Figures 17-28.
精密度Precision
取供试品溶液,按确定的色谱条件连续进样6次,各主要色谱峰峰面积的RSD小于5%,表明进样精密度良好,结果见表2。The test solution was taken and continuously injected 6 times according to the determined chromatographic conditions. The RSD of each major peak area was less than 5%, indicating that the injection precision was good, and the results are shown in Table 2.
表2精密度考察结果
Figure PCTCN2017075513-appb-000008
Table 2 precision inspection results
Figure PCTCN2017075513-appb-000008
重复性Repeatability
取本发明中药组合物内容物6份,按已确定的“供试品溶液制备方法”制备,注入液相色谱仪检测,测定各主要色谱峰峰面积的RSD均小于5%,表明方法重复性较好,结果见表3。Taking 6 parts of the content of the traditional Chinese medicine composition of the present invention, prepared according to the determined "preparation method of the test solution", and injecting into a liquid chromatograph to determine that the RSD of each major peak area is less than 5%, indicating the method repeatability. Preferably, the results are shown in Table 3.
表3重复性考察结果 Table 3 results of repetitive investigation
Figure PCTCN2017075513-appb-000009
Figure PCTCN2017075513-appb-000009
稳定性stability
取供试品溶液,分别在0h,2h,4h,8h,12h,24h进样,测定各主要色谱峰峰面积的RSD均小于10%,表明供试品溶液在24h内稳定,结果见表4。The test solution was taken at 0h, 2h, 4h, 8h, 12h, 24h, and the RSD of each major peak area was less than 10%, indicating that the test solution was stable within 24h. The results are shown in Table 4. .
表4稳定性考察结果Table 4 stability investigation results
Figure PCTCN2017075513-appb-000010
Figure PCTCN2017075513-appb-000010
Figure PCTCN2017075513-appb-000011
Figure PCTCN2017075513-appb-000011
指纹图谱的建立及相似度分析Fingerprint Mapping and Similarity Analysis
8.1指纹图谱的建立:取10批本发明中药组合物样品,按3.4项下要求制备供试品溶液,在上述色谱条件下进样分析,得到10批本发明中药组合物的指纹图谱,并采用国家药典委员会开发的中药色谱指纹图谱相似度评价系统2004A版软件对10批样品的指纹图谱进行分析,采用中位数法对各指纹图谱色谱峰进行了多点校正和自动匹配,计算相似度并生成对照指纹图谱,见附图29-30,相似度结果见表5,指纹图谱中共有色谱峰16个,用标准品指认了其中9个共有峰:新绿原酸(2号峰),绿原酸(3号峰),隐绿原酸(5号峰),异连翘酯苷A(8号峰),连翘酯苷A(11号峰),槲皮苷(13号峰),4,5-二-O-咖啡酰奎宁酸(14号峰),连翘苷(15号峰),甘草酸(16号峰)。其中以出峰稳定,峰面积较大的11号色谱峰连翘酯苷A为参照峰:8.1 Fingerprint establishment: Take 10 batches of the sample of the traditional Chinese medicine composition of the invention, prepare the test solution according to the requirements of 3.4, and carry out the sample analysis under the above chromatographic conditions to obtain the fingerprints of 10 batches of the traditional Chinese medicine composition of the invention, and adopt The Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2004A version developed by the National Pharmacopoeia Committee analyzed the fingerprints of 10 batches of samples. The median method was used to correct and automatically match the chromatographic peaks of each fingerprint to calculate the similarity. A comparison fingerprint was generated, as shown in Figure 29-30. The similarity results are shown in Table 5. There are 16 chromatographic peaks in the fingerprint, and 9 common peaks were identified by standard: new chlorogenic acid (peak 2), green Acid (peak 3), cryptochlorogenic acid (peak 5), forsythine A (peak 8), forsythiaside A (peak 11), quercetin (peak 13), 4 , 5-di-O-caffeoylquinic acid (peak 14), forsythin (peak 15), glycyrrhizic acid (peak 16). Among them, the 11th chromatographic peak forsythiaside A with stable peak and large peak area is the reference peak:
表5  10批中药组合物胶囊中间体指纹图谱相似度Table 5 Fingerprint similarity of capsules in 10 batches of traditional Chinese medicine composition
Figure PCTCN2017075513-appb-000012
Figure PCTCN2017075513-appb-000012
本发明建立了本发明中药组合物的液相指纹图谱方法,共有色谱峰16个,用标准品指认了其中9个共有峰:新绿原酸(2号峰),绿原酸(3号峰),隐绿原酸(5号峰),异连翘酯苷A(8号峰),连翘酯苷A(11号峰),槲皮苷(13号峰),4,5-二-O-咖啡酰奎宁酸(14号峰),连翘苷(15号峰),甘草酸(16号峰)。其中以出峰稳定,峰面积较大的11号色谱峰连翘酯苷A为参照峰,10批本发明中药组合物指纹图谱的相似度较高。由以上实验结果可知,本方法具有良好的精密度和稳定性,以及重复性,为提高该中药组合物的质量控制提供一种新方法。The invention establishes a liquid phase fingerprinting method of the traditional Chinese medicine composition of the invention, which has 16 chromatographic peaks, and 9 common peaks are identified by standard products: new chlorogenic acid (peak No. 2) and chlorogenic acid (peak No. 3). , cryptochlorogenic acid (peak 5), forsythine A (peak 8), forsythiaside A (peak 11), quercetin (peak 13), 4,5-di-O - caffeoyl quinic acid (peak 14), forsythin (peak 15), glycyrrhizic acid (peak 16). Among them, the 11th chromatographic peak forsythiaside A with a stable peak and a large peak area was used as a reference peak, and the similarity of the fingerprints of the 10 batches of the traditional Chinese medicine composition of the present invention was high. It can be seen from the above experimental results that the method has good precision and stability, and repeatability, and provides a new method for improving the quality control of the traditional Chinese medicine composition.
附图说明DRAWINGS
图1:检测波长320nm下供试品溶液色谱图Figure 1: Chromatogram of the test solution at a detection wavelength of 320 nm
图2:检测波长290nm下供试品溶液色谱图Figure 2: Chromatogram of the test solution at a detection wavelength of 290 nm
图3:检测波长254nm下供试品溶液色谱图Figure 3: Chromatogram of the test solution at a detection wavelength of 254 nm
图4:检测波长230nm下供试品溶液色谱图Figure 4: Chromatogram of the test solution at a detection wavelength of 230 nm
图5:甲醇-0.1%磷酸供试品溶液色谱图Figure 5: Chromatogram of methanol-0.1% phosphoric acid test solution
图6:乙腈-0.1%磷酸供试品溶液色谱图Figure 6: Chromatogram of acetonitrile-0.1% phosphoric acid test solution
图7:甲醇-乙腈-0.1%磷酸供试品溶液色谱图Figure 7: Chromatogram of methanol-acetonitrile-0.1% phosphoric acid test solution
图8:50%甲醇提取供试品溶液色谱图Figure 8: Chromatogram of 50% methanol extraction test solution
图9:70%甲醇提取供试品溶液色谱图Figure 9: Chromatogram of 70% methanol extraction test solution
图10:90%甲醇提取供试品溶液色谱图Figure 10: Chromatogram of 90% methanol extraction test solution
图11:甲醇提取供试品溶液色谱图Figure 11: Chromatogram of methanol extraction test solution
图12:超声30分钟供试品溶液色谱图 Figure 12: Chromatogram of the sample solution for 30 minutes of ultrasound
图13:回流1小时供试品溶液色谱图Figure 13: Chromatogram of the test solution for 1 hour of reflux
图14:超声20分钟供试品溶液色谱图Figure 14: Chromatogram of the test solution for 20 minutes of ultrasound
图15:超声30分钟供试品溶液色谱图Figure 15: Chromatogram of the sample solution for 30 minutes of ultrasound
图16:超声40分钟供试品溶液色谱图Figure 16: Chromatogram of the solution for 40 minutes of ultrasound
图17:对照品溶液的色谱图Figure 17: Chromatogram of the reference solution
图18:连翘酯苷A参照物溶液的色谱图Figure 18: Chromatogram of the forsythiaside A reference solution
图19:供试品溶液的色谱图Figure 19: Chromatogram of the test solution
图20:对照品溶液与供试品溶液中新绿原酸光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 20: Comparison of the spectrum of the new chlorogenic acid in the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
图21:对照品溶液与供试品溶液中绿原酸光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 21: Comparison of the chlorogenic acid spectrum of the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
图22:对照品溶液与供试品溶液中隐绿原酸光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 22: Comparison of the spectrum of the cryptochlorogenic acid in the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
图23:对照品溶液与供试品溶液中异连翘酯苷A光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 23: Comparison of the reference solution of the reference solution with the testosterone A in the test solution, the dotted line is the spectrum of the test sample, and the solid line is the spectrum of the reference product.
图24:对照品溶液与供试品溶液中连翘酯苷A光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 24: Comparison of the reference solution of forsythiaside A in the reference solution and the test solution, the dotted line is the spectrum of the test sample, and the solid line is the spectrum of the reference product.
图25:对照品溶液与供试品溶液中槲皮苷光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 25: Comparison of the quercetin spectrum of the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
图26:对照品溶液与供试品溶液中4,5-二-O-咖啡酰奎宁酸光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 26: Comparison of the spectrum of 4,5-di-O-caffeoylquinic acid in the reference solution and the test solution. The dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
图27:对照品溶液与供试品溶液中连翘苷光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 27: Comparison of the forsythiaside spectra of the reference solution and the test solution, the dotted line is the spectrum of the test sample, and the solid line is the reference spectrum of the reference product.
图28:对照品溶液与供试品溶液中甘草酸光谱图比较,虚线为供试品光谱图,实线为对照品光谱图Figure 28: Comparison of the spectrum of glycyrrhizic acid in the reference solution and the test solution, the dotted line is the spectrum of the sample, and the solid line is the spectrum of the reference.
图29:10批本发明中药组合物色谱指纹图谱Figure 29: Chromatographic fingerprint of 10 batches of traditional Chinese medicine composition of the present invention
图30:本发明中药组合物对照指纹图谱Figure 30: Control fingerprint of traditional Chinese medicine composition of the present invention
图31:实施例1指纹图谱,其中A图中峰1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为连翘酯苷A,6为槲皮苷,7为4,5-二-O-咖啡酰奎宁酸,8为连翘苷,9为甘草酸;B图为连翘酯苷A参照物溶液的色谱图;C为供试品溶液指纹色谱图Figure 31: Fingerprint of Example 1, wherein the peak 1 in Figure A is new chlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is berberine A, and 5 is forsythiaside A. 6 is quercetin, 7 is 4,5-di-O-caffeoylquinic acid, 8 is forsythin, 9 is glycyrrhizic acid; B is a chromatogram of forsythiaside A reference solution; C is Fingerprint chromatogram of test solution
图32:实施例2指纹图谱,其中A图中峰1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为连翘酯苷A,6为槲皮苷,7为4,5-二-O-咖啡酰奎宁酸,8为连翘苷,9为甘草酸;B图为连翘酯苷A参照物溶液的色谱图;C为供试品溶液指纹色谱图Figure 32: Fingerprint of Example 2, wherein the peak 1 in Figure A is new chlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is berberine A, and 5 is forsythiaside A. 6 is quercetin, 7 is 4,5-di-O-caffeoylquinic acid, 8 is forsythin, 9 is glycyrrhizic acid; B is a chromatogram of forsythiaside A reference solution; C is Fingerprint chromatogram of test solution
图33:实施例3指纹图谱,其中A图中峰1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为连翘酯苷A,6为槲皮苷,7为4,5-二-O-咖啡酰奎宁酸,8为连翘苷,9为甘草酸;B图为连翘酯苷A参照物溶液的色谱图;C为供试品溶液指纹色谱图Figure 33: Fingerprint of Example 3, wherein the peak 1 in Figure A is neochlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is isopenic acid ester A, and 5 is forsythiaside A. 6 is quercetin, 7 is 4,5-di-O-caffeoylquinic acid, 8 is forsythin, 9 is glycyrrhizic acid; B is a chromatogram of forsythiaside A reference solution; C is Fingerprint chromatogram of test solution
图34:实施例4指纹图谱,其中A图中峰1为新绿原酸,2为绿原酸,3为隐绿原酸,4为异连翘酯苷A,5为连翘酯苷A,6为槲皮苷,7为4,5-二-O-咖啡酰奎宁酸,8为连翘苷,9为甘草酸;B图为连翘酯苷A参照物溶液的色谱图;C为供试品溶液指纹色谱图Figure 34: Fingerprint of Example 4, wherein the peak 1 in Figure A is new chlorogenic acid, 2 is chlorogenic acid, 3 is cryptochlorogenic acid, 4 is berberine A, and 5 is forsythiaside A. 6 is quercetin, 7 is 4,5-di-O-caffeoylquinic acid, 8 is forsythin, 9 is glycyrrhizic acid; B is a chromatogram of forsythiaside A reference solution; C is Fingerprint chromatogram of test solution
具体实施方式detailed description
实施例1Example 1
按比例称取:连翘200g、金银花300g、板蓝根200g、大黄40g、广藿香60g、绵马贯众300g、红景天100g、薄荷脑9g、麻黄60g、苦杏仁100g、鱼腥草200g、甘草100g、石膏200g,按照以下工艺提取:Weighed according to the ratio: Forsythia 200g, Honeysuckle 300g, Radix Isatidis 200g, Rhubarb 40g, Patchouli 60g, Mianma Guanzhong 300g, Rhodiola 100g, Menthol 9g, Ephedra 60g, Bitter Almond 100g, Houttuynia 200g, Licorice 100g, gypsum 200g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤 液备用;(3) Forsythia, Ephedra, Houttuynia cordata and Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, and the ethanol is recovered and filtered. Liquid reserve
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,装胶囊,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, and capsules are obtained.
指纹图谱测定方法:Fingerprint measurement method:
供试品溶液制备:取所述中药组合物0.25g,精密称定,置具塞锥形瓶中,精密加入50%甲醇25mL,称定重量,超声功率500W,频率40kHz,超声30分钟,放冷,再称定重量,用50%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.25g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 50mL methanol 25mL, weigh the weight, ultrasonic power 500W, frequency 40kHz, ultrasonic 30 minutes, put Cold, weigh the weight again, make up the lost weight with 50% methanol, shake it, filter it, take the filtrate, and get it;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000013
Figure PCTCN2017075513-appb-000013
色谱柱为Waters Acquity UPLC HSS T3色谱柱,柱长为100mm,内径为2.1mm,粒径为1.8μm;检测波长239nm,流速0.3ml/min;The column was a Waters Acquity UPLC HSS T3 column with a column length of 100 mm, an inner diameter of 2.1 mm, a particle size of 1.8 μm, a detection wavelength of 239 nm, and a flow rate of 0.3 ml/min;
测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入超高液相色谱仪,测定,记录色谱图,即得。Assay method: accurately draw 2 μL of each of the reference solution and the test solution, inject into an ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
结论:指纹图谱见附图31,结果令人满意可以用于控制该中药组合物的质量。Conclusion: The fingerprint is shown in Figure 31, and the results are satisfactory for controlling the quality of the Chinese medicine composition.
实施例2Example 2
按比例称取:连翘300g、金银花200g、板蓝根300g、大黄60g、广藿香100g、绵马贯众200g、红景天60g、薄荷脑5g、麻黄100g、苦杏仁60g、鱼腥草300g、甘草60g、石膏300g,按照以下工艺提取:Weighed in proportion: Forsythia 300g, Honeysuckle 200g, Radix Isatidis 300g, Rhubarb 60g, Patchouli 100g, Mianma Guanzhong 200g, Rhodiola 60g, Menthol 5g, Ephedra 100g, Bitter Almond 60g, Houttuynia 300g, Glycyrrhiza 60g, gypsum 300g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断; (1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,压片,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed and tableted.
指纹图谱测定方法:Fingerprint measurement method:
供试品溶液制备:取所述中药组合物0.1g,精密称定,置具塞锥形瓶中,精密加入100%甲醇50mL,称定重量,超声处理40分钟,放冷,再称定重量,用100%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.1g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 50mL of methanol, 50mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight. , use 100% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000014
Figure PCTCN2017075513-appb-000014
色谱柱为Waters Acquity UPLC HSS T3(柱长为100mm,内径为2.1mm,粒径为1.8μm)色谱柱;检测波长239nm,流速0.1ml/min;The column was a Waters Acquity UPLC HSS T3 (column length 100 mm, inner diameter 2.1 mm, particle size 1.8 μm) column; detection wavelength 239 nm, flow rate 0.1 ml / min;
测定法:分别精密吸取对照品溶液与供试品溶液各1μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 1 μL of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
结论:指纹图谱见附图32,结果令人满意可以用于控制该中药组合物的质量。Conclusion: The fingerprint is shown in Figure 32. The results are satisfactory and can be used to control the quality of the Chinese herbal composition.
实施例3Example 3
原料药配方为:连翘278g、金银花294g、板蓝根285g、大黄55g、广藿香95g、绵马贯众290g、红景天87g、 薄荷脑8.5g、麻黄88g、苦杏仁80g、鱼腥草284g、甘草95g、石膏277g,按照以下工艺提取:The raw material formula is: 278g forsythia, 294g for honeysuckle, 285g for radix isatidis, 55g for rhubarb, 95g for patchouli, 290g for cotton horse, and 87g for Rhodiola Menthol 8.5g, ephedra 88g, bitter almond 80g, houttuynia 284g, licorice 95g, gypsum 277g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,装袋,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, and the bag is obtained.
指纹图谱测定方法:Fingerprint measurement method:
供试品溶液制备:取所述中药组合物0.5g,精密称定,置具塞锥形瓶中,精密加入40%甲醇10mL,称定重量,超声处理20分钟,放冷,再称定重量,用40%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 40mL methanol to 10mL, weigh the weight, sonicate for 20 minutes, let cool, then weigh the weight. , use 40% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000015
Figure PCTCN2017075513-appb-000015
色谱柱为Waters XBridgeTM Shield RP18(5μm,4.6mm×250mm)色谱柱;检测波长239nm,流速0.5ml/min;The column was Waters XBridge TM Shield RP18 (5μm, 4.6mm × 250mm) column; detection wavelength 239nm, flow rate 0.5ml / min;
测定法:分别精密吸取对照品溶液与供试品溶液各1μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 1 μL of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
结果:指纹图谱见附图33,结果令人满意可以用于控制该中药组合物的质量。Results: The fingerprint is shown in Figure 33 and the results were satisfactory to control the quality of the Chinese herbal composition.
实施例4 Example 4
原料药配方为:按比例称取:连翘255g、金银花255g、板蓝根255g、大黄51g、广藿香85g、绵马贯众255g、红景天85g、薄荷脑7.5g、麻黄85g、苦杏仁85g、鱼腥草255g、甘草85g、石膏255g,按照以下工艺提取:The raw material formula is: weighed according to the ratio: Forsythia 255g, Honeysuckle 255g, Radix Isatidis 255g, Rhubarb 51g, Patchouli 85g, Mianma Guanzhong 255g, Rhodiola 85g, Menthol 7.5g, Ephedra 85g, Bitter Almond 85g Houttuynia 255g, licorice 85g, gypsum 255g, extracted according to the following process:
(1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
(2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
(3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
(4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
(5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥,得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying to obtain a dry paste powder, which is used;
(6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
(7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,装胶囊,即得。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, and capsules are obtained.
指纹图谱测定方法:Fingerprint measurement method:
供试品溶液制备:取所述中药组合物0.2g,精密称定,置具塞锥形瓶中,精密加入90%甲醇20mL,称定重量,超声处理40分钟,放冷,再称定重量,用90%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.2g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 20mL of methanol 20mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight , use 90% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml 4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg /ml ammonium glycyrrhizinate mixed control solution is obtained;
参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得。Preparation of the reference solution: Take the appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make a solution containing 101.2 μg per 1 ml, that is.
色谱条件:流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:Chromatographic conditions: the mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, gradient elution procedure was:
Figure PCTCN2017075513-appb-000016
Figure PCTCN2017075513-appb-000016
色谱柱为Phenomenex Kinetx XB-C18色谱柱;检测波长239nm,流速0.4ml/min;The column was a Phenomenex Kinetx XB-C18 column; the detection wavelength was 239 nm, and the flow rate was 0.4 ml/min;
测定法:分别精密吸取对照品溶液与供试品溶液各6μL,注入超高液相色谱仪,测定,记录色谱图,即得。Assay method: accurately draw 6 μL of each of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
结论:指纹图谱见附图34,结果令人满意可以用于控制该中药组合物的质量。 Conclusion: The fingerprint is shown in Figure 34 and the results are satisfactory for controlling the quality of the Chinese herbal composition.

Claims (14)

  1. 一种中药组合物的指纹图谱测定方法,该中药组合物的原料药包括:连翘、麻黄、大黄、鱼腥草、金银花、板蓝根、广藿香、绵马贯众、红景天、薄荷脑、苦杏仁、甘草、石膏,其特征在于,所述指纹图谱测定方法包括如下步骤:A method for determining a fingerprint of a traditional Chinese medicine composition, the raw materials of the traditional Chinese medicine composition include: forsythia, ephedra, rhubarb, houttuynia, honeysuckle, radix isatidis, patchouli, Mianma Guanzhong, Rhodiola, menthol , bitter almond, licorice, gypsum, wherein the fingerprinting method comprises the following steps:
    供试品溶液制备:取中药组合物,加有机溶剂提取,得供试品溶液;Preparation of the test solution: taking the traditional Chinese medicine composition, and extracting with an organic solvent to obtain a test solution;
    对照品溶液的制备:分别取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,加有机溶剂溶解,得对照品溶液;Preparation of reference solution: fresh chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoylquinine The acid, quercetin, ammonium glycyrrhizinate reference substance is dissolved in an organic solvent to obtain a reference solution;
    参照物溶液的制备:取连翘酯苷A对照品适量,加有机溶剂溶解,得参照物溶液;Preparation of the reference solution: take appropriate amount of forsythiaside A reference substance, add organic solvent to dissolve, to obtain a reference solution;
    色谱条件:以甲醇-乙腈-磷酸水溶液为流动相,梯度洗脱,所述磷酸水溶液浓度为0.1%~0.5%;Chromatographic conditions: a methanol-acetonitrile-phosphoric acid aqueous solution as a mobile phase, gradient elution, the concentration of the aqueous phosphoric acid solution is 0.1% to 0.5%;
    测定法:分别吸取对照品溶液与供试品溶液,注入液相色谱仪,测定,即得。Determination method: separately draw the reference solution and the test solution, inject into the liquid chromatograph, and measure, that is, obtain.
  2. 如权利要求1所述的指纹图谱测定方法,其特征在于,所述有机溶剂包括50%~100%的甲醇溶液、50%~100%的乙醇溶液。The fingerprinting method according to claim 1, wherein the organic solvent comprises 50% to 100% of a methanol solution and 50% to 100% of an ethanol solution.
  3. 如权利要求1所述的指纹图谱测定方法,其特征在于,所述梯度洗脱程序为:The method of determining a fingerprint according to claim 1, wherein said gradient elution program is:
    Figure PCTCN2017075513-appb-100001
    Figure PCTCN2017075513-appb-100001
  4. 如权利要求1所述的指纹图谱测定方法,其特征在于,检测波长为200-250nm。The fingerprint mapping method according to claim 1, wherein the detection wavelength is 200 to 250 nm.
  5. 如权利要求1所述的指纹图谱测定方法,其特征在于,该中药组合物由如下重量份的原料药制成:连翘200-300、麻黄60-100、大黄40-60、鱼腥草200-300、金银花200-300、板蓝根200-300、广藿香60-100、绵马贯众200-300、红景天60-100、薄荷脑5-9、苦杏仁60-100、甘草60-100、石膏200-300;所述指纹图谱测定方法如下:The method for determining a fingerprint according to claim 1, wherein the traditional Chinese medicine composition is made of the following raw materials by weight: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia cordata 200 -300, honeysuckle 200-300, Banlangen 200-300, patchouli 60-100, Mianma Guanzhong 200-300, Rhodiola 60-100, menthol 5-9, bitter almond 60-100, licorice 60- 100, gypsum 200-300; the fingerprinting method is as follows:
    供试品溶液制备:取所述中药组合物0.1-0.5g,精密称定,置具塞锥形瓶中,精密加入40-100%甲醇10-50mL,称定重量,超声处理20-40分钟,放冷,再称定重量,用40-100%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.1-0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 40-100% methanol 10-50mL, weigh the weight, sonicate for 20-40 minutes , let cool, then weigh the weight, make up the lost weight with 40-100% methanol, shake, filter, take the filtrate, get it;
    对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得; Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg/ Methyl glycyrrhizinate mixed control solution is obtained;
    参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得;Preparation of reference solution: Take appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make 101.2μg solution per 1ml, that is;
    流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:The mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, and the gradient elution procedure was:
    Figure PCTCN2017075513-appb-100002
    Figure PCTCN2017075513-appb-100002
    色谱柱为C18色谱柱;检测波长239nm,流速0.1-0.5ml/min;The column is a C 18 column; the detection wavelength is 239 nm, and the flow rate is 0.1-0.5 ml/min;
    测定法:分别精密吸取对照品溶液与供试品溶液各1-10μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw the reference solution and the test solution each 1-10μL, inject into the ultra-high liquid chromatograph, determine, record the chromatogram, that is.
  6. 如权利要求5所述的指纹图谱测定方法,其特征在于所述中药组合物制剂是由如下重量份的原料药制成:The method of determining a fingerprint according to claim 5, wherein the preparation of the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘200、金银花300、板蓝根200、大黄40、广藿香60、绵马贯众300、红景天100、薄荷脑9、麻黄60、苦杏仁100、鱼腥草200、甘草100、石膏200。Forsythia 200, Honeysuckle 300, Banlangen 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60, Bitter Almond 100, Houttuynia 200, Licorice 100, Gypsum 200 .
  7. 如权利要求5所述的指纹图谱测定方法,其特征在于所述中药组合物制剂由下列重量份的原料药制成:The method of determining a fingerprint according to claim 5, wherein the preparation of the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘300、金银花200、板蓝根300、大黄60、广藿香100、绵马贯众200、红景天60、薄荷脑5、麻黄100、苦杏仁60、鱼腥草300、甘草60、石膏300。Forsythia 300, Honeysuckle 200, Banlangen 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100, Bitter Almond 60, Houttuynia 300, Licorice 60, Gypsum 300 .
  8. 如权利要求5所述的指纹图谱测定方法,其特征在于所述中药组合物制剂由下列重量份的原料药制成:The method of determining a fingerprint according to claim 5, wherein the preparation of the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘278、金银花294、板蓝根285、大黄55、广藿香95、绵马贯众290、红景天87、薄荷脑8.5、麻黄88、苦杏仁80、鱼腥草284、甘草95、石膏277。Forsythia 278, Honeysuckle 294, Banlangen 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88, Bitter Almond 80, Houttuynia 284, Licorice 95, Gypsum 277 .
  9. 如权利要求5所述的指纹图谱测定方法,其特征在于所述中药组合物制剂由下列重量份的原料药制成:The method of determining a fingerprint according to claim 5, wherein the preparation of the traditional Chinese medicine composition is made of the following raw materials by weight:
    连翘255、金银花255、板蓝根255、大黄51、广藿香85、绵马贯众255、红景天85、薄荷脑7.5、麻黄85、苦杏仁85、鱼腥草255、甘草85、石膏255。Forsythia 255, Honeysuckle 255, Banlangen 255, Rhubarb 51, Patchouli 85, Mianma Guanzhong 255, Rhodiola 85, Menthol 7.5, Ephedra 85, Bitter Almond 85, Houttuynia 255, Licorice 85, Gypsum 255 .
  10. 如权利要求1-9任一项所述的指纹图谱测定方法,其特征在于所述中药组合物制剂的制备方法为:The method for determining a fingerprint according to any one of claims 1 to 9, wherein the preparation method of the traditional Chinese medicine composition preparation is:
    (1)按照原料药重量比例称取中药材,净选,酌情碎断;(1) Weigh Chinese medicines according to the weight ratio of raw materials, net selection, and break as appropriate;
    (2)广藿香碎断,加10倍量水提取挥发油,提油时间8小时,收集挥发油,备用;提取液过滤后,残渣弃去,滤液备用;(2) Patchouli scented, add 10 times the amount of water to extract volatile oil, oil extraction time 8 hours, collect volatile oil, spare; after the extract is filtered, the residue is discarded, the filtrate is reserved;
    (3)连翘、麻黄、鱼腥草、大黄,用12倍量70%的乙醇提取3次,每次2.5小时,提取液合并过滤,回收乙醇,滤液备用;(3) Forsythia, Ephedra, Houttuynia cordata, Rhubarb, extracted with 12 times 70% ethanol for 3 times, each time for 2.5 hours, the extract is combined with filtration, ethanol is recovered, and the filtrate is reserved;
    (4)金银花、石膏、板蓝根、绵马贯众、甘草、红景天,加12倍量水煎煮至沸,加入苦杏仁,煎煮2次,每次1小时,提取液合并过滤,所得滤液与步骤(2)广藿香提油后的滤液合并,浓缩成在60℃时测定相对密度为1.10-1.15的清膏,加入乙醇,调节至醇浓度为70%,冷藏放置,过滤,回收乙醇至无醇味,得清膏备用;(4) Honeysuckle, gypsum, Banlangen, Mianma Guanzhong, Licorice, Rhodiola, add 12 times the amount of water to boil, add bitter almonds, decoct 2 times, each time for 1 hour, extract and filter, the result The filtrate is combined with the filtrate of step (2) patchouli oil extraction, and concentrated to obtain a clear paste having a relative density of 1.10-15.15 at 60 ° C, added with ethanol, adjusted to an alcohol concentration of 70%, refrigerated, filtered, and recovered. Ethanol to no alcohol, get a clear paste;
    (5)将步骤(4)所得清膏与步骤(3)所得醇提液合并,浓缩至在60℃时测定相对密度为1.15-1.20的清膏,干燥, 得干膏粉,备用;(5) Combining the clear paste obtained in the step (4) with the alcohol extract obtained in the step (3), and concentrating to obtain a clear paste having a relative density of 1.15 - 1.20 at 60 ° C, and drying. Get dry powder, spare;
    (6)将步骤(5)所得干膏粉加入适当药学上可接受的辅料制粒;(6) adding the dry paste powder obtained in the step (5) to a suitable pharmaceutically acceptable auxiliary material for granulation;
    (7)将薄荷脑、步骤(2)所得挥发油加入乙醇溶解,喷入步骤(6)所得颗粒,密闭,混匀,压片或者装胶囊、或者装袋。(7) The menthol and the volatile oil obtained in the step (2) are dissolved in ethanol, and the granules obtained in the step (6) are sprayed, sealed, mixed, tableted or capsuled, or bagged.
  11. 如权利要求1-9任一项所述的指纹图谱测定方法,其特征在于所述指纹图谱测定方法如下:The fingerprint mapping method according to any one of claims 1 to 9, wherein the fingerprinting method is as follows:
    供试品溶液制备:取所述中药组合物0.25g,精密称定,置具塞锥形瓶中,精密加入50%甲醇25mL,称定重量,超声功率500W,频率40kHz,超声30分钟,放冷,再称定重量,用50%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.25g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, precisely add 50mL methanol 25mL, weigh the weight, ultrasonic power 500W, frequency 40kHz, ultrasonic 30 minutes, put Cold, weigh the weight again, make up the lost weight with 50% methanol, shake it, filter it, take the filtrate, and get it;
    对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg/ Methyl glycyrrhizinate mixed control solution is obtained;
    参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得;Preparation of reference solution: Take appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make 101.2μg solution per 1ml, that is;
    流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:The mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, and the gradient elution procedure was:
    Figure PCTCN2017075513-appb-100003
    Figure PCTCN2017075513-appb-100003
    色谱柱为Waters Acquity UPLC HSS T3色谱柱,柱长为100mm,内径为2.1mm,粒径为1.8μm;检测波长239nm,流速0.3ml/min;The column was a Waters Acquity UPLC HSS T3 column with a column length of 100 mm, an inner diameter of 2.1 mm, a particle size of 1.8 μm, a detection wavelength of 239 nm, and a flow rate of 0.3 ml/min;
    测定法:分别精密吸取对照品溶液与供试品溶液各2μL,注入超高液相色谱仪,测定,记录色谱图,即得。Assay method: accurately draw 2 μL of each of the reference solution and the test solution, inject into an ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  12. 如权利要求1-9任一项所述的指纹图谱测定方法,其特征在于所述指纹图谱测定方法如下:The fingerprint mapping method according to any one of claims 1 to 9, wherein the fingerprinting method is as follows:
    供试品溶液制备:取所述中药组合物0.1g,精密称定,置具塞锥形瓶中,精密加入100%甲醇50mL,称定重量,超声处理40分钟,放冷,再称定重量,用100%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.1g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 50mL of methanol, 50mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight. , use 100% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
    对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg/ Methyl glycyrrhizinate mixed control solution is obtained;
    参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得;Preparation of reference solution: Take appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make 101.2μg solution per 1ml, that is;
    流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为: The mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, and the gradient elution procedure was:
    Figure PCTCN2017075513-appb-100004
    Figure PCTCN2017075513-appb-100004
    色谱柱为Waters Acquity UPLC HSS T3色谱柱;检测波长239nm,流速0.1ml/min;The column was a Waters Acquity UPLC HSS T3 column; the detection wavelength was 239 nm, and the flow rate was 0.1 ml/min;
    测定法:分别精密吸取对照品溶液与供试品溶液各1μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 1 μL of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  13. 如权利要求1-9任一项所述的指纹图谱测定方法,其特征在于所述指纹图谱测定方法如下:The fingerprint mapping method according to any one of claims 1 to 9, wherein the fingerprinting method is as follows:
    供试品溶液制备:取所述中药组合物0.5g,精密称定,置具塞锥形瓶中,精密加入40%甲醇10mL,称定重量,超声处理20分钟,放冷,再称定重量,用40%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.5g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 40mL methanol to 10mL, weigh the weight, sonicate for 20 minutes, let cool, then weigh the weight. , use 40% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
    对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg/ Methyl glycyrrhizinate mixed control solution is obtained;
    参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得;Preparation of reference solution: Take appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make 101.2μg solution per 1ml, that is;
    流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:The mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, and the gradient elution procedure was:
    Figure PCTCN2017075513-appb-100005
    Figure PCTCN2017075513-appb-100005
    色谱柱为Waters XBridgeTMShield RP18;检测波长239nm,流速0.5ml/min; The column was Waters XBridge TM Shield RP18; detection wavelength 239nm, flow rate 0.5ml / min;
    测定法:分别精密吸取对照品溶液与供试品溶液各1μL,注入超高液相色谱仪,测定,记录色谱图,即得。Determination method: respectively, accurately draw 1 μL of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
  14. 如权利要求1-9任一项所述的指纹图谱测定方法,其特征在于所述指纹图谱测定方法如下:The fingerprint mapping method according to any one of claims 1 to 9, wherein the fingerprinting method is as follows:
    供试品溶液制备:取所述中药组合物0.2g,精密称定,置具塞锥形瓶中,精密加入90%甲醇20mL,称定重量,超声处理40分钟,放冷,再称定重量,用90%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得;Preparation of test solution: Take 0.2g of the traditional Chinese medicine composition, accurately weigh it, place it in a conical flask, accurately add 20mL of methanol 20mL, weigh the weight, sonicate for 40 minutes, let cool, then weigh the weight , use 90% methanol to make up the lost weight, shake, filter, and take the filtrate to obtain;
    对照品溶液的制备:分别称取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、连翘酯苷A、连翘苷、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品适量,制成分别含18.4μg/ml新绿原酸、27.2μg/ml绿原酸、21.2μg/ml隐绿原酸、27.2μg/ml异连翘酯苷A、21.6μg/ml连翘酯苷A、16.0μg/ml连翘苷、14.4μg/ml4,5-二-O-咖啡酰奎宁酸、9.0μg/ml槲皮苷、24.4μg/ml甘草酸铵混合对照品溶液即得;Preparation of reference solution: weigh new chlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isophoric acid A, forsythiaside A, forsythin, 4,5-di-O-caffeoyl The appropriate amount of linic acid, quercetin and ammonium glycyrrhizinate was prepared to contain 18.4 μg/ml neochlorogenic acid, 27.2 μg/ml chlorogenic acid, 21.2 μg/ml cryptochlorogenic acid, and 27.2 μg/ml. Ester A, 21.6 μg/ml forsythiaside A, 16.0 μg/ml forsythin, 14.4 μg/ml 4,5-di-O-caffeoylquinic acid, 9.0 μg/ml quercetin, 24.4 μg/ Methyl glycyrrhizinate mixed control solution is obtained;
    参照物溶液的制备:取连翘酯苷A对照品适量,精密称定,加50%甲醇制成每1ml含101.2μg的溶液,即得;Preparation of reference solution: Take appropriate amount of forsythiaside A reference substance, accurately weighed, add 50% methanol to make 101.2μg solution per 1ml, that is;
    流动相为甲醇-乙腈-0.1%磷酸,梯度洗脱,梯度洗脱程序为:The mobile phase was methanol-acetonitrile-0.1% phosphoric acid, gradient elution, and the gradient elution procedure was:
    Figure PCTCN2017075513-appb-100006
    Figure PCTCN2017075513-appb-100006
    色谱柱为Phenomenex Kinetx XB-C18;检测波长239nm,流速0.4ml/min;The column was Phenomenex Kinetx XB-C18; the detection wavelength was 239 nm, and the flow rate was 0.4 ml/min;
    测定法:分别精密吸取对照品溶液与供试品溶液各6μL,注入超高液相色谱仪,测定,记录色谱图,即得。 Assay method: accurately draw 6 μL of each of the reference solution and the test solution, inject into the ultra-high liquid chromatograph, measure and record the chromatogram, that is, obtain.
PCT/CN2017/075513 2016-03-03 2017-03-03 Method for determining fingerprint of chinese medicine composition WO2017148426A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610119793.8 2016-03-03
CN201610119793.8A CN107153098B (en) 2016-03-03 2016-03-03 Method for measuring fingerprint spectrum of traditional Chinese medicine composition

Publications (1)

Publication Number Publication Date
WO2017148426A1 true WO2017148426A1 (en) 2017-09-08

Family

ID=59743593

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/075513 WO2017148426A1 (en) 2016-03-03 2017-03-03 Method for determining fingerprint of chinese medicine composition

Country Status (2)

Country Link
CN (1) CN107153098B (en)
WO (1) WO2017148426A1 (en)

Cited By (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108459110A (en) * 2018-05-09 2018-08-28 国珍健康科技(北京)有限公司 A method of chlorogenic acid is measured by high performance liquid chromatography
CN108645921A (en) * 2018-01-24 2018-10-12 吉林修正药业新药开发有限公司 A kind of construction method of the HPLC finger-prints of Chinese patent drug " XIAOMI SHUAN "
CN109633043A (en) * 2019-02-27 2019-04-16 通化玉圣药业有限公司 A kind of method for building up and its standard diagram of gadol injection HPLC finger-print
WO2019091287A1 (en) * 2017-11-10 2019-05-16 石家庄以岭药业股份有限公司 Method for separating eight components in chinese traditional medicine composition
CN110208400A (en) * 2019-05-21 2019-09-06 新疆农业科学院农产品贮藏加工研究所 A kind of method of various of monomer phenol content in measurement jujube
CN110376305A (en) * 2019-07-26 2019-10-25 淮阴工学院 A kind of content assaying method of wormwood artemisia tea Content of Chlorogenic Acid class
CN111323504A (en) * 2020-03-16 2020-06-23 浙江凯润药业股份有限公司 Yiqing granule fingerprint spectrum quality control method
CN111830170A (en) * 2020-07-24 2020-10-27 陕西康城药业股份有限公司 Method for measuring content of antiviral mixture in four seasons
CN111983121A (en) * 2020-07-03 2020-11-24 湖南旻一生物科技有限公司 Quality control method and quality control spectrogram of non-volatile components of Chinese medicinal sachet, and construction method thereof
CN112014481A (en) * 2019-05-29 2020-12-01 湖北梦阳药业股份有限公司 Detection method of fingerprint spectrum of Shengbai oral liquid
CN112076151A (en) * 2020-08-28 2020-12-15 乐泰药业有限公司 A Chinese medicinal oral liquid for treating diabetes due to deficiency of both qi and yin, and its preparation method and quality control method
CN112098556A (en) * 2020-09-21 2020-12-18 山东宏济堂制药集团股份有限公司 Detection method of angelica sinensis Liuhuang decoction
CN112268976A (en) * 2020-09-11 2021-01-26 浙江磐康药业有限公司 Establishment method of HPLC fingerprint for distinguishing rubus chingii and rubus suavissimus and fingerprint
CN112268968A (en) * 2020-10-16 2021-01-26 山东步长神州制药有限公司 Detection method of fingerprint spectrum of medicinal preparation
CN112326806A (en) * 2019-07-20 2021-02-05 神威药业集团有限公司 Albizzia julibrissin formula particle HPLC characteristic spectrum and construction method and application thereof
CN112394126A (en) * 2020-11-30 2021-02-23 天津中新药业集团股份有限公司隆顺榕制药厂 Extraction and detection method and application of chlorogenic acid in solanum dulcamara
CN112505170A (en) * 2020-11-11 2021-03-16 成都中医药大学 Qinglong white tiger soup and quality detection method thereof
CN112557526A (en) * 2020-11-16 2021-03-26 成都市食品药品检验研究院 Quality-controllable isatis root extract and method for identifying isatis root containing raw material medicine in Chinese patent medicine
CN112557563A (en) * 2019-09-10 2021-03-26 泰州医药城国科化物生物医药科技有限公司 Method for identifying medicinal material fructus aurantii in western and Jiangxi regions
CN112578029A (en) * 2019-09-29 2021-03-30 天津同仁堂集团股份有限公司 Lung-clearing decoction preparation HPLC quality control construction method and application thereof
CN112710765A (en) * 2019-10-24 2021-04-27 泰州医药城国科化物生物医药科技有限公司 Fingerprint detection method of gardenia medicinal material and application thereof
CN112834672A (en) * 2020-12-31 2021-05-25 四川新绿色药业科技发展有限公司 Construction and detection method of rangooncreeper fruit formula particle characteristic spectrum
CN112858529A (en) * 2021-03-12 2021-05-28 内蒙古奥特奇蒙药股份有限公司 Detection method of three-ingredient rheum officinale preparation
CN112870376A (en) * 2021-01-27 2021-06-01 上海硕方医药科技有限公司 Traditional Chinese medicine extracting solution concentrating and defoaming method and application thereof
CN112903844A (en) * 2021-01-19 2021-06-04 皖西学院 Detection method for content of pteridophytin in fiddlehead
CN112946113A (en) * 2021-02-01 2021-06-11 湖北医药学院 Method for identifying genuine medicinal material Shiweir fructus forsythiae basal source
CN113125628A (en) * 2021-03-12 2021-07-16 河北锦坤动物药业有限公司 Thin-layer chromatography identification method for radix sophorae flavescentis and radix sophorae flavescentis in three-flavor bistort oral liquid
CN113138238A (en) * 2021-04-15 2021-07-20 河南省纳普生物技术有限公司 Method for detecting content of 8 flavone and phenolic acid components in camelina sativa seeds
CN113156017A (en) * 2021-04-26 2021-07-23 陕西汉王药业股份有限公司 Method for simultaneously determining contents of 12 chemical components in strong dizzy-stop tablet by adopting HPLC (high performance liquid chromatography)
CN113156019A (en) * 2021-04-28 2021-07-23 重庆市畜牧科学院 Method for detecting multi-component content of liquorice heart-fire-purging decoction
CN113176366A (en) * 2021-05-08 2021-07-27 宁夏医科大学 Evaluation method of secondary refined polysaccharide and flavonoid components based on spectral efficiency relationship
CN113341031A (en) * 2021-07-21 2021-09-03 青海省中医院 Method for identifying quality goods, counterfeit goods and substitutes of rhodiola root medicinal materials
CN113376273A (en) * 2021-06-02 2021-09-10 国药集团精方(安徽)药业股份有限公司 Detection method of HPLC (high performance liquid chromatography) characteristic spectrum of Qingxin lotus seed drink and application of characteristic spectrum
CN113418996A (en) * 2021-05-13 2021-09-21 江西普正制药股份有限公司 Callicarpa nudiflora antibacterial action substance evaluation method based on spectrum effect correlation
CN113466361A (en) * 2021-06-18 2021-10-01 广西壮族自治区中医药研究院 Method for evaluating quality of gastrointestinal powder
CN113588808A (en) * 2021-06-25 2021-11-02 西安千禾药业股份有限公司 Content determination method for simultaneously detecting multiple effective components in Xueping capsules
CN113588800A (en) * 2020-04-30 2021-11-02 河北凯盛医药科技有限公司 Preparation and detection method of substance standard of classical famous prescription Xiebai powder
CN113759038A (en) * 2021-08-26 2021-12-07 北京康仁堂药业有限公司 Trachelospermi caulis characteristic map, construction method and quality control method thereof, Trachelospermi caulis formula granules and preparation method thereof
CN113791165A (en) * 2021-09-13 2021-12-14 湖南新汇制药股份有限公司 Quality detection method for fried fructus viticis standard decoction
CN113834883A (en) * 2021-06-22 2021-12-24 海南葫芦娃药业集团股份有限公司 Method for determining content of fructus forsythiae in infantile lung heat cough and asthma granules
CN113917041A (en) * 2021-11-01 2022-01-11 湖南新汇制药股份有限公司 Quality detection method for standard decoction of moutan bark
CN113945674A (en) * 2021-12-20 2022-01-18 江西省药品检验检测研究院 Characteristic spectrum and analysis method of processed rehmannia root product
CN113960214A (en) * 2021-11-09 2022-01-21 上海海虹实业(集团)巢湖今辰药业有限公司 Rhizoma atractylodis macrocephalae component selection method based on rhizoma alismatis decoction
CN113960184A (en) * 2021-02-05 2022-01-21 株洲千金药业股份有限公司 Establishment and quality detection method of blood-replenishing and motherwort-tonifying pill fingerprint spectrum
CN113960210A (en) * 2021-10-31 2022-01-21 江苏海洋大学 Detection method of high performance liquid chromatography fingerprint of pharbitis seed
CN113960213A (en) * 2021-11-09 2022-01-21 上海海虹实业(集团)巢湖今辰药业有限公司 Alisma orientale component selection method based on alisma orientale decoction
CN114152686A (en) * 2021-11-10 2022-03-08 湖南易能生物医药有限公司 Fingerprint construction method and application of traditional Chinese medicine compound containing cinnamon
CN114166958A (en) * 2021-10-29 2022-03-11 合肥创新医药技术有限公司 Fingerprint detection method and application of traditional Chinese medicine compound cang huo pingwei granules
CN114235974A (en) * 2021-11-05 2022-03-25 武汉人福创新药物研发中心有限公司 Method for detecting rutin, isoquercitrin and rosmarinic acid content in herba Hedyotidis Diffusae or its extract
CN114252511A (en) * 2020-09-21 2022-03-29 厦门中药厂有限公司 Method for detecting fingerprint of Babaodan, standard fingerprint of Babaodan and application
CN114354828A (en) * 2021-12-29 2022-04-15 甘肃奇正藏药有限公司 Leptochloa brachypomum characteristic spectrum, construction method thereof and quality detection method of Leptochloa brachypomum
CN114414670A (en) * 2021-10-29 2022-04-29 柳州市妇幼保健院 Establishment method of zanthoxylum bungeanum fingerprint and zanthoxylum bungeanum fingerprint
CN114441685A (en) * 2022-02-08 2022-05-06 湖南新汇制药股份有限公司 Quality detection method for rhizoma paridis standard decoction
CN114460191A (en) * 2022-01-20 2022-05-10 广西壮族自治区食品药品检验所 Method for measuring content of digitoxin D in Tianwang heart tonifying preparation
CN114515301A (en) * 2020-11-19 2022-05-20 国药集团同济堂(贵州)制药有限公司 Flatstem milkvetch seed standard decoction, preparation method and detection method
CN114609291A (en) * 2022-03-22 2022-06-10 国药集团精方(安徽)药业股份有限公司 Fingerprint detection method for compound Chinese medicinal decoction
CN114636760A (en) * 2020-12-15 2022-06-17 云南雷允上理想药业有限公司 Fingerprint spectrum establishment method and application of traditional Chinese medicine composition for treating kidney diseases
CN114689712A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for channel warming decoction extract
CN114689780A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for Baoyin decoction extract
CN114689710A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for loquat lung-clearing drink extract
CN114720569A (en) * 2020-12-22 2022-07-08 云南雷允上理想药业有限公司 Fingerprint spectrum establishment method of achyranthes bidentata medicinal material and application thereof
CN114755338A (en) * 2022-04-19 2022-07-15 四川新绿色药业科技发展有限公司 Detection method of agastache rugosus and preparation thereof
CN114894917A (en) * 2022-04-06 2022-08-12 山东步长制药股份有限公司 Detection and fingerprint spectrum construction method for volatile components of nardostachys chinensis bunge
CN114942291A (en) * 2022-06-20 2022-08-26 江苏省中医院 Method for detecting quality of 'Zhenyang Yangyin' granule
CN114990054A (en) * 2022-07-22 2022-09-02 成都艾伟孚生物科技有限公司 Formula of sperm-washing and fertilization liquid for assisted reproduction
CN115032311A (en) * 2022-07-11 2022-09-09 景忠山国药(唐山)有限公司 Xinnaoxin medicine component content determination method based on one-measurement-multiple evaluation method
CN115184493A (en) * 2022-07-06 2022-10-14 株洲市食品药品检验所 Fingerprint detection method for active ingredients in taxus mairei medicinal material and traditional Chinese medicine decoction pieces thereof
CN115201376A (en) * 2022-07-18 2022-10-18 国药集团精方(安徽)药业股份有限公司 Quality detection method of loquat cough relieving granules
CN115326981A (en) * 2022-08-22 2022-11-11 贵州医科大学 Method for measuring contents of various components in Tougu medical material
CN115327007A (en) * 2022-08-17 2022-11-11 浙江双石药业有限公司 Method for detecting fingerprint spectrum of ephedra decoction
CN115343388A (en) * 2022-08-04 2022-11-15 中山市中医院 Method for evaluating quality of sophora japonica particles by using one-test-multiple evaluation method
CN115343395A (en) * 2022-08-26 2022-11-15 华颐药业有限公司 Establishment method of UPLC fingerprint of dispersible decoction, standard fingerprint and application thereof
CN115372510A (en) * 2022-08-16 2022-11-22 云南植物药业有限公司 Hypocrellum bambusoides fingerprint spectrum and establishing method and application thereof
CN115372501A (en) * 2022-07-27 2022-11-22 广州科曼生物科技有限公司 Thunberg fritillary bulb or Hubei fritillary bulb contrast extract and preparation method and application thereof
CN115389654A (en) * 2022-08-04 2022-11-25 华润三九现代中药制药有限公司 Method for constructing fingerprint spectrum of centipeda minima medicinal preparation and content testing method
CN115452971A (en) * 2022-08-17 2022-12-09 神威药业集团有限公司 Method for analyzing chemical components of Shengyu decoction based on UPLC-Q-TOF-MS technology and identification
CN115452996A (en) * 2022-09-23 2022-12-09 江苏省中医院 Quality detection method of traditional Chinese medicine compound preparation for treating viral upper respiratory infection
CN115494181A (en) * 2022-10-17 2022-12-20 山东省食品药品检验研究院 Detection method for simultaneously identifying five raw material medicines in collateral-dredging and phlegm-reducing capsule
CN116106452A (en) * 2023-02-27 2023-05-12 浙江景岳堂药业有限公司 Construction method of stevia rebaudiana formula granule characteristic spectrum, characteristic spectrum constructed by method and application of characteristic spectrum
CN114184700B (en) * 2021-12-06 2023-08-22 内蒙古民族大学 Method for measuring chemical component content of Mongolian medicine costa
CN117233306A (en) * 2023-11-16 2023-12-15 江西省药品检验检测研究院 Fingerprint establishment and component content determination method for jindan Fuyan particles
CN115326981B (en) * 2022-08-22 2024-04-30 贵州医科大学 Method for measuring content of various components in garden balsam medicinal material

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109668970B (en) * 2017-10-13 2020-11-10 石家庄以岭药业股份有限公司 Ultra-high performance liquid chromatography detection method for traditional Chinese medicine composition
CN109187820B (en) * 2018-11-09 2021-07-23 湖南国华制药有限公司 Method for establishing UPLC fingerprint of compound formula chinaroot greenbrier granules
CN111766308B (en) * 2019-03-28 2023-11-10 石家庄以岭药业股份有限公司 Fingerprint spectrum measuring method for traditional Chinese medicine composition preparation
CN110632232B (en) * 2019-10-22 2021-09-24 山东省中医药研究院 Method for establishing fingerprint spectrum of fructus forsythiae medicinal material
CN110716001B (en) * 2019-11-29 2020-07-07 山东汉方制药有限公司 Method for detecting characteristic spectrum of compound phellodendron amurense liquid preparation
CN110850019B (en) * 2019-11-29 2022-02-18 南京南医堂健康产业发展有限公司 Method for detecting fingerprint of Minggu Shuqing drink
CN115718145A (en) * 2021-08-24 2023-02-28 河北以岭医药研究院有限公司 Method for measuring fingerprint spectrum of traditional Chinese medicine composition
CN114062553A (en) * 2021-11-17 2022-02-18 荣昌制药(淄博)有限公司 Method for measuring HPLC fingerprint of child six-ingredient appetite increasing ointment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683421A (en) * 2008-09-26 2010-03-31 北京以岭药业有限公司 Applications of traditional Chinese medicine composition in preparation of medicament for treating repetitive respiratory tract infection
CN103800523A (en) * 2012-11-13 2014-05-21 河北以岭医药研究院有限公司 Method for preparing anti-virus traditional Chinese medicinal composition and finger-print detection method
CN104345111A (en) * 2013-08-08 2015-02-11 河北以岭医药研究院有限公司 Determination method for content of multiple active compositions in traditional Chinese medicine composition preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1194752C (en) * 2003-07-01 2005-03-30 河北以岭医药研究院有限公司 Anti-virus Chinese medicine composition and preparation process thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683421A (en) * 2008-09-26 2010-03-31 北京以岭药业有限公司 Applications of traditional Chinese medicine composition in preparation of medicament for treating repetitive respiratory tract infection
CN103800523A (en) * 2012-11-13 2014-05-21 河北以岭医药研究院有限公司 Method for preparing anti-virus traditional Chinese medicinal composition and finger-print detection method
CN104345111A (en) * 2013-08-08 2015-02-11 河北以岭医药研究院有限公司 Determination method for content of multiple active compositions in traditional Chinese medicine composition preparation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Liquorice", PHARMACOPOEIA OF THE PEOPLE'S REPUBLIC OF CHINA, vol. I, 30 June 2015 (2015-06-30), pages 86 - 87 *
CHEN, KUIXIA ET AL.: "Simultaneous Quantification of Ten Phenolic Acids in Lonicerae Japonicae Flos by HPLC-DAD", JOURNAL OF CHINESE PHARMACEUTICAL SCIENCES, vol. 22, no. 6, 31 December 2013 (2013-12-31), pages 521 - 526 *
LUO, BIN ET AL.: "Study on Chemical Constituents of Extract of Forsythia Suspense", CHINESE JOURNAL OF EXPERIMENTAL TRADITIONAL MEDICAL FORMULAE, vol. 19, no. 3, 28 February 2013 (2013-02-28), pages 143 - 146 *
SHEN, JUAN ET AL.: "Determination of Organic Acids and Glycosides in Different Species of Lonicerae Flos", CHINESE HERBAL MEDICINES, vol. 45, no. 20, 31 December 2014 (2014-12-31), pages 2993 - 2996 *
YU , JIANPING ET AL.: "Quantitative Determination of Quercitrin in Houttuynia Cordata by High Performance Liquid Chromatography", HERALD OF MEDICINE, vol. 27, no. 3, 31 March 2008 (2008-03-31), pages 331 *
ZHANG, YONGFENG ET AL.: "Rapid Determination of Ingredients in Water Extract of Lianhua Qingwen Capsule by UPLC", CHINESE JOURNAL OF MODERN APPLIED PHARMACY, vol. 31, no. 1, 31 January 2014 (2014-01-31), pages 78 - 80, XP055414053 *

Cited By (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019091287A1 (en) * 2017-11-10 2019-05-16 石家庄以岭药业股份有限公司 Method for separating eight components in chinese traditional medicine composition
US11564966B2 (en) 2017-11-10 2023-01-31 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Method for separating eight components in Chinese traditional medicine composition
CN108645921A (en) * 2018-01-24 2018-10-12 吉林修正药业新药开发有限公司 A kind of construction method of the HPLC finger-prints of Chinese patent drug " XIAOMI SHUAN "
CN108645921B (en) * 2018-01-24 2022-08-26 通药制药集团股份有限公司 Method for constructing HPLC fingerprint of Chinese patent medicine' Xiaomi Shuan
CN108459110A (en) * 2018-05-09 2018-08-28 国珍健康科技(北京)有限公司 A method of chlorogenic acid is measured by high performance liquid chromatography
CN109633043A (en) * 2019-02-27 2019-04-16 通化玉圣药业有限公司 A kind of method for building up and its standard diagram of gadol injection HPLC finger-print
CN110208400A (en) * 2019-05-21 2019-09-06 新疆农业科学院农产品贮藏加工研究所 A kind of method of various of monomer phenol content in measurement jujube
CN110208400B (en) * 2019-05-21 2023-09-19 新疆农业科学院农产品贮藏加工研究所 Method for determining phenol content of various monomers in red dates
CN112014481A (en) * 2019-05-29 2020-12-01 湖北梦阳药业股份有限公司 Detection method of fingerprint spectrum of Shengbai oral liquid
CN112014481B (en) * 2019-05-29 2022-10-25 湖北梦阳药业股份有限公司 Detection method of raw white oral liquid fingerprint spectrum
CN112326806B (en) * 2019-07-20 2022-11-04 神威药业集团有限公司 Albizzia julibrissin formula particle HPLC characteristic spectrum and construction method and application thereof
CN112326806A (en) * 2019-07-20 2021-02-05 神威药业集团有限公司 Albizzia julibrissin formula particle HPLC characteristic spectrum and construction method and application thereof
CN110376305A (en) * 2019-07-26 2019-10-25 淮阴工学院 A kind of content assaying method of wormwood artemisia tea Content of Chlorogenic Acid class
CN112557563A (en) * 2019-09-10 2021-03-26 泰州医药城国科化物生物医药科技有限公司 Method for identifying medicinal material fructus aurantii in western and Jiangxi regions
CN112578029B (en) * 2019-09-29 2022-10-04 天津同仁堂集团股份有限公司 HPLC detection method for lung clearing decoction preparation and application thereof
CN112578029A (en) * 2019-09-29 2021-03-30 天津同仁堂集团股份有限公司 Lung-clearing decoction preparation HPLC quality control construction method and application thereof
CN112710765A (en) * 2019-10-24 2021-04-27 泰州医药城国科化物生物医药科技有限公司 Fingerprint detection method of gardenia medicinal material and application thereof
CN111323504B (en) * 2020-03-16 2022-09-06 浙江凯润药业股份有限公司 Yiqing granule fingerprint spectrum quality control method
CN111323504A (en) * 2020-03-16 2020-06-23 浙江凯润药业股份有限公司 Yiqing granule fingerprint spectrum quality control method
CN113588800A (en) * 2020-04-30 2021-11-02 河北凯盛医药科技有限公司 Preparation and detection method of substance standard of classical famous prescription Xiebai powder
CN111983121A (en) * 2020-07-03 2020-11-24 湖南旻一生物科技有限公司 Quality control method and quality control spectrogram of non-volatile components of Chinese medicinal sachet, and construction method thereof
CN111830170A (en) * 2020-07-24 2020-10-27 陕西康城药业股份有限公司 Method for measuring content of antiviral mixture in four seasons
CN112076151B (en) * 2020-08-28 2023-04-18 乐泰药业有限公司 A Chinese medicinal oral liquid for treating diabetes due to deficiency of both qi and yin, and its preparation method and quality control method
CN112076151A (en) * 2020-08-28 2020-12-15 乐泰药业有限公司 A Chinese medicinal oral liquid for treating diabetes due to deficiency of both qi and yin, and its preparation method and quality control method
CN112268976B (en) * 2020-09-11 2022-05-20 浙江磐康药业有限公司 Establishment method of HPLC fingerprint for distinguishing rubus chingii and rubus suavissimus and fingerprint
CN112268976A (en) * 2020-09-11 2021-01-26 浙江磐康药业有限公司 Establishment method of HPLC fingerprint for distinguishing rubus chingii and rubus suavissimus and fingerprint
CN112098556B (en) * 2020-09-21 2022-08-30 山东宏济堂制药集团股份有限公司 Detection method of angelica sinensis Liuhuang decoction
CN114252511A (en) * 2020-09-21 2022-03-29 厦门中药厂有限公司 Method for detecting fingerprint of Babaodan, standard fingerprint of Babaodan and application
CN114252511B (en) * 2020-09-21 2023-05-12 厦门中药厂有限公司 Method for detecting eight-treasure pill fingerprint and eight-treasure pill standard fingerprint and application
CN112098556A (en) * 2020-09-21 2020-12-18 山东宏济堂制药集团股份有限公司 Detection method of angelica sinensis Liuhuang decoction
CN112268968A (en) * 2020-10-16 2021-01-26 山东步长神州制药有限公司 Detection method of fingerprint spectrum of medicinal preparation
CN112505170B (en) * 2020-11-11 2022-03-08 成都中医药大学 Qinglong white tiger soup and quality detection method thereof
CN112505170A (en) * 2020-11-11 2021-03-16 成都中医药大学 Qinglong white tiger soup and quality detection method thereof
CN112557526A (en) * 2020-11-16 2021-03-26 成都市食品药品检验研究院 Quality-controllable isatis root extract and method for identifying isatis root containing raw material medicine in Chinese patent medicine
CN112557526B (en) * 2020-11-16 2022-07-19 成都市药品检验研究院 Quality-controllable isatis root extract and method for identifying isatis root containing raw material medicine in Chinese patent medicine
CN114515301B (en) * 2020-11-19 2024-03-29 国药集团同济堂(贵州)制药有限公司 Semen astragali Complanati standard decoction, and preparation method and detection method thereof
CN114515301A (en) * 2020-11-19 2022-05-20 国药集团同济堂(贵州)制药有限公司 Flatstem milkvetch seed standard decoction, preparation method and detection method
CN112394126A (en) * 2020-11-30 2021-02-23 天津中新药业集团股份有限公司隆顺榕制药厂 Extraction and detection method and application of chlorogenic acid in solanum dulcamara
CN114636760B (en) * 2020-12-15 2024-01-02 云南雷允上理想药业有限公司 Fingerprint spectrum establishment method of traditional Chinese medicine composition for treating kidney diseases and application of fingerprint spectrum establishment method
CN114636760A (en) * 2020-12-15 2022-06-17 云南雷允上理想药业有限公司 Fingerprint spectrum establishment method and application of traditional Chinese medicine composition for treating kidney diseases
CN114720569A (en) * 2020-12-22 2022-07-08 云南雷允上理想药业有限公司 Fingerprint spectrum establishment method of achyranthes bidentata medicinal material and application thereof
CN114689710A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for loquat lung-clearing drink extract
CN114689780A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for Baoyin decoction extract
CN114689712A (en) * 2020-12-29 2022-07-01 四川新绿色药业科技发展有限公司 Multi-component quality detection method for channel warming decoction extract
CN114689712B (en) * 2020-12-29 2023-10-03 四川新绿色药业科技发展有限公司 Multi-component quality detection method for channel warming soup extract
CN114689710B (en) * 2020-12-29 2023-10-03 四川新绿色药业科技发展有限公司 Multi-component quality detection method for loquat lung-heat-clearing drink extract
CN114689780B (en) * 2020-12-29 2023-10-03 四川新绿色药业科技发展有限公司 Multi-component quality detection method for Baoyin decoction extract
CN112834672A (en) * 2020-12-31 2021-05-25 四川新绿色药业科技发展有限公司 Construction and detection method of rangooncreeper fruit formula particle characteristic spectrum
CN112834672B (en) * 2020-12-31 2023-09-08 四川新绿色药业科技发展有限公司 Construction and detection method of feature map of rangooncreeper fruit formula granule
CN112903844A (en) * 2021-01-19 2021-06-04 皖西学院 Detection method for content of pteridophytin in fiddlehead
CN112870376A (en) * 2021-01-27 2021-06-01 上海硕方医药科技有限公司 Traditional Chinese medicine extracting solution concentrating and defoaming method and application thereof
CN112946113B (en) * 2021-02-01 2022-09-30 湖北医药学院 Method for identifying genuine medicinal material Shiweir fructus forsythiae basal source
CN112946113A (en) * 2021-02-01 2021-06-11 湖北医药学院 Method for identifying genuine medicinal material Shiweir fructus forsythiae basal source
CN113960184A (en) * 2021-02-05 2022-01-21 株洲千金药业股份有限公司 Establishment and quality detection method of blood-replenishing and motherwort-tonifying pill fingerprint spectrum
CN112858529A (en) * 2021-03-12 2021-05-28 内蒙古奥特奇蒙药股份有限公司 Detection method of three-ingredient rheum officinale preparation
CN113125628A (en) * 2021-03-12 2021-07-16 河北锦坤动物药业有限公司 Thin-layer chromatography identification method for radix sophorae flavescentis and radix sophorae flavescentis in three-flavor bistort oral liquid
CN113138238A (en) * 2021-04-15 2021-07-20 河南省纳普生物技术有限公司 Method for detecting content of 8 flavone and phenolic acid components in camelina sativa seeds
CN113156017A (en) * 2021-04-26 2021-07-23 陕西汉王药业股份有限公司 Method for simultaneously determining contents of 12 chemical components in strong dizzy-stop tablet by adopting HPLC (high performance liquid chromatography)
CN113156019A (en) * 2021-04-28 2021-07-23 重庆市畜牧科学院 Method for detecting multi-component content of liquorice heart-fire-purging decoction
CN113176366A (en) * 2021-05-08 2021-07-27 宁夏医科大学 Evaluation method of secondary refined polysaccharide and flavonoid components based on spectral efficiency relationship
CN113418996A (en) * 2021-05-13 2021-09-21 江西普正制药股份有限公司 Callicarpa nudiflora antibacterial action substance evaluation method based on spectrum effect correlation
CN113376273B (en) * 2021-06-02 2023-03-17 国药集团精方(安徽)药业股份有限公司 Detection method of HPLC (high performance liquid chromatography) characteristic spectrum of Qingxin lotus seed drink and application of characteristic spectrum
CN113376273A (en) * 2021-06-02 2021-09-10 国药集团精方(安徽)药业股份有限公司 Detection method of HPLC (high performance liquid chromatography) characteristic spectrum of Qingxin lotus seed drink and application of characteristic spectrum
CN113466361A (en) * 2021-06-18 2021-10-01 广西壮族自治区中医药研究院 Method for evaluating quality of gastrointestinal powder
CN113834883B (en) * 2021-06-22 2023-05-26 海南葫芦娃药业集团股份有限公司 Method for measuring content of forsythin in children's lung heat cough and asthma granule
CN113834883A (en) * 2021-06-22 2021-12-24 海南葫芦娃药业集团股份有限公司 Method for determining content of fructus forsythiae in infantile lung heat cough and asthma granules
CN113588808A (en) * 2021-06-25 2021-11-02 西安千禾药业股份有限公司 Content determination method for simultaneously detecting multiple effective components in Xueping capsules
CN113588808B (en) * 2021-06-25 2023-02-28 西安千禾药业股份有限公司 Content determination method for simultaneously detecting multiple active ingredients in Xueping capsules
CN113341031A (en) * 2021-07-21 2021-09-03 青海省中医院 Method for identifying quality goods, counterfeit goods and substitutes of rhodiola root medicinal materials
CN113759038B (en) * 2021-08-26 2023-04-07 北京康仁堂药业有限公司 Trachelospermi caulis characteristic map, construction method and quality control method thereof, trachelospermi caulis formula granules and preparation method thereof
CN113759038A (en) * 2021-08-26 2021-12-07 北京康仁堂药业有限公司 Trachelospermi caulis characteristic map, construction method and quality control method thereof, Trachelospermi caulis formula granules and preparation method thereof
CN113791165A (en) * 2021-09-13 2021-12-14 湖南新汇制药股份有限公司 Quality detection method for fried fructus viticis standard decoction
CN113791165B (en) * 2021-09-13 2023-09-26 湖南新汇制药股份有限公司 Quality detection method for stir-fried fructus viticis standard decoction
CN114166958A (en) * 2021-10-29 2022-03-11 合肥创新医药技术有限公司 Fingerprint detection method and application of traditional Chinese medicine compound cang huo pingwei granules
CN114166958B (en) * 2021-10-29 2024-03-29 合肥创新医药技术有限公司 Detection method of fingerprint of traditional Chinese medicine compound herba xanthil stomach-calming particles and application thereof
CN114414670A (en) * 2021-10-29 2022-04-29 柳州市妇幼保健院 Establishment method of zanthoxylum bungeanum fingerprint and zanthoxylum bungeanum fingerprint
CN113960210A (en) * 2021-10-31 2022-01-21 江苏海洋大学 Detection method of high performance liquid chromatography fingerprint of pharbitis seed
CN113917041B (en) * 2021-11-01 2024-03-15 湖南新汇制药股份有限公司 Quality detection method for cortex moutan standard decoction
CN113917041A (en) * 2021-11-01 2022-01-11 湖南新汇制药股份有限公司 Quality detection method for standard decoction of moutan bark
CN114235974A (en) * 2021-11-05 2022-03-25 武汉人福创新药物研发中心有限公司 Method for detecting rutin, isoquercitrin and rosmarinic acid content in herba Hedyotidis Diffusae or its extract
CN113960214A (en) * 2021-11-09 2022-01-21 上海海虹实业(集团)巢湖今辰药业有限公司 Rhizoma atractylodis macrocephalae component selection method based on rhizoma alismatis decoction
CN113960213A (en) * 2021-11-09 2022-01-21 上海海虹实业(集团)巢湖今辰药业有限公司 Alisma orientale component selection method based on alisma orientale decoction
CN114152686A (en) * 2021-11-10 2022-03-08 湖南易能生物医药有限公司 Fingerprint construction method and application of traditional Chinese medicine compound containing cinnamon
CN114152686B (en) * 2021-11-10 2023-11-03 湖南易能生物医药有限公司 Fingerprint construction method of traditional Chinese medicine compound containing cinnamon and application of fingerprint construction method
CN114184700B (en) * 2021-12-06 2023-08-22 内蒙古民族大学 Method for measuring chemical component content of Mongolian medicine costa
CN113945674A (en) * 2021-12-20 2022-01-18 江西省药品检验检测研究院 Characteristic spectrum and analysis method of processed rehmannia root product
CN114354828B (en) * 2021-12-29 2023-11-03 甘肃奇正藏药有限公司 Characteristic spectrum of herba Lagotis Brevibacterium, construction method thereof and quality detection method of herba Lagotis Brevibacterium
CN114354828A (en) * 2021-12-29 2022-04-15 甘肃奇正藏药有限公司 Leptochloa brachypomum characteristic spectrum, construction method thereof and quality detection method of Leptochloa brachypomum
CN114460191A (en) * 2022-01-20 2022-05-10 广西壮族自治区食品药品检验所 Method for measuring content of digitoxin D in Tianwang heart tonifying preparation
CN114441685A (en) * 2022-02-08 2022-05-06 湖南新汇制药股份有限公司 Quality detection method for rhizoma paridis standard decoction
CN114441685B (en) * 2022-02-08 2023-06-27 湖南新汇制药股份有限公司 Paris polyphylla standard decoction quality detection method
CN114609291B (en) * 2022-03-22 2023-12-26 国药集团精方(安徽)药业股份有限公司 Fingerprint detection method for traditional Chinese medicine compound consistent decoction
CN114609291A (en) * 2022-03-22 2022-06-10 国药集团精方(安徽)药业股份有限公司 Fingerprint detection method for compound Chinese medicinal decoction
CN114894917A (en) * 2022-04-06 2022-08-12 山东步长制药股份有限公司 Detection and fingerprint spectrum construction method for volatile components of nardostachys chinensis bunge
CN114894917B (en) * 2022-04-06 2023-10-20 山东步长制药股份有限公司 Method for detecting volatile components of rhizoma nardostachyos and constructing fingerprint
CN114755338B (en) * 2022-04-19 2023-10-20 四川新绿色药业科技发展有限公司 Detection method of wrinkled giant hyssop and preparation thereof
CN114755338A (en) * 2022-04-19 2022-07-15 四川新绿色药业科技发展有限公司 Detection method of agastache rugosus and preparation thereof
CN114942291B (en) * 2022-06-20 2024-03-12 江苏省中医院 Quality detection method of yang-suppressing yin-nourishing particles
CN114942291A (en) * 2022-06-20 2022-08-26 江苏省中医院 Method for detecting quality of 'Zhenyang Yangyin' granule
CN115184493A (en) * 2022-07-06 2022-10-14 株洲市食品药品检验所 Fingerprint detection method for active ingredients in taxus mairei medicinal material and traditional Chinese medicine decoction pieces thereof
CN115032311B (en) * 2022-07-11 2024-03-22 景忠山国药(唐山)有限公司 Method for measuring content of Xinnaoxin medicine components based on one-measurement-multiple-evaluation method
CN115032311A (en) * 2022-07-11 2022-09-09 景忠山国药(唐山)有限公司 Xinnaoxin medicine component content determination method based on one-measurement-multiple evaluation method
CN115201376A (en) * 2022-07-18 2022-10-18 国药集团精方(安徽)药业股份有限公司 Quality detection method of loquat cough relieving granules
CN114990054A (en) * 2022-07-22 2022-09-02 成都艾伟孚生物科技有限公司 Formula of sperm-washing and fertilization liquid for assisted reproduction
CN115372501B (en) * 2022-07-27 2024-03-26 广州科曼生物科技有限公司 Control extract of fritillaria thunbergii or fritillaria hubei, preparation method and application thereof
CN115372501A (en) * 2022-07-27 2022-11-22 广州科曼生物科技有限公司 Thunberg fritillary bulb or Hubei fritillary bulb contrast extract and preparation method and application thereof
CN115343388B (en) * 2022-08-04 2023-09-08 中山市中医院 Method for evaluating quality of pagodatree flower particles by using one-test-multiple-evaluation method
CN115389654A (en) * 2022-08-04 2022-11-25 华润三九现代中药制药有限公司 Method for constructing fingerprint spectrum of centipeda minima medicinal preparation and content testing method
CN115389654B (en) * 2022-08-04 2023-10-27 华润三九现代中药制药有限公司 Construction method and content testing method of fingerprint of centipeda minima medicinal preparation
CN115343388A (en) * 2022-08-04 2022-11-15 中山市中医院 Method for evaluating quality of sophora japonica particles by using one-test-multiple evaluation method
CN115372510A (en) * 2022-08-16 2022-11-22 云南植物药业有限公司 Hypocrellum bambusoides fingerprint spectrum and establishing method and application thereof
CN115372510B (en) * 2022-08-16 2024-03-15 云南植物药业有限公司 Hypocrellin fingerprint and establishment method and application thereof
CN115327007A (en) * 2022-08-17 2022-11-11 浙江双石药业有限公司 Method for detecting fingerprint spectrum of ephedra decoction
CN115452971A (en) * 2022-08-17 2022-12-09 神威药业集团有限公司 Method for analyzing chemical components of Shengyu decoction based on UPLC-Q-TOF-MS technology and identification
CN115326981A (en) * 2022-08-22 2022-11-11 贵州医科大学 Method for measuring contents of various components in Tougu medical material
CN115326981B (en) * 2022-08-22 2024-04-30 贵州医科大学 Method for measuring content of various components in garden balsam medicinal material
CN115343395B (en) * 2022-08-26 2023-12-26 华颐药业有限公司 Establishment method of UPLC fingerprint of scattered decoction and standard fingerprint and application thereof
CN115343395A (en) * 2022-08-26 2022-11-15 华颐药业有限公司 Establishment method of UPLC fingerprint of dispersible decoction, standard fingerprint and application thereof
CN115452996B (en) * 2022-09-23 2024-02-02 江苏省中医院 Quality detection method of traditional Chinese medicine compound preparation for treating viral upper respiratory tract infection
CN115452996A (en) * 2022-09-23 2022-12-09 江苏省中医院 Quality detection method of traditional Chinese medicine compound preparation for treating viral upper respiratory infection
CN115494181A (en) * 2022-10-17 2022-12-20 山东省食品药品检验研究院 Detection method for simultaneously identifying five raw material medicines in collateral-dredging and phlegm-reducing capsule
CN116106452A (en) * 2023-02-27 2023-05-12 浙江景岳堂药业有限公司 Construction method of stevia rebaudiana formula granule characteristic spectrum, characteristic spectrum constructed by method and application of characteristic spectrum
CN117233306B (en) * 2023-11-16 2024-01-30 江西省药品检验检测研究院 Fingerprint establishment and component content determination method for jindan Fuyan particles
CN117233306A (en) * 2023-11-16 2023-12-15 江西省药品检验检测研究院 Fingerprint establishment and component content determination method for jindan Fuyan particles

Also Published As

Publication number Publication date
CN107153098B (en) 2021-05-04
CN107153098A (en) 2017-09-12

Similar Documents

Publication Publication Date Title
WO2017148426A1 (en) Method for determining fingerprint of chinese medicine composition
WO2017148418A1 (en) Method for determining component contents of chinese medicine composition
CN101991661B (en) Method for detecting Chinese patent drug containing at least two of white paeony root, ginseng, salvia miltiorrhiza, sweet wormwood, liquorice and angelica sinensis
CN105738546B (en) Method for establishing fingerprint of radix curcumae medicinal material and fingerprint thereof
CN111624271A (en) Liquid chromatography method for detecting corresponding substance of peony and licorice decoction, standard fingerprint spectrum and application
CN107991425B (en) Detection method of traditional Chinese medicine composition for treating traumatic injury
CN101766771A (en) Quality control method of medicine for gynecopathy treatment
CN109374764B (en) HPLC fingerprint spectrum and main component content determination method for eight-ingredient Longzui granules
CN101966223A (en) Fingerprint detection method for compound wintercreeper preparation
CN105301168B (en) The detection method of dredging collateral resolving sputum capsule
CN106290599B (en) Content determination method of traditional Chinese medicine composition
CN109668970B (en) Ultra-high performance liquid chromatography detection method for traditional Chinese medicine composition
CN101513467A (en) Method for controlling quality of dermatosis toxemia preparation
CN106370756B (en) A kind of detection method of Chinese materia medica preparation that preventing and treating infectious bronchitis of chicken
CN108459128B (en) Quality control method of angelica sinensis Sini decoction composition
CN102068598B (en) Quality control method of Yangrong Baicao Wan for treating irregular menses caused by hemophthisis
CN108020613B (en) Method for measuring content of menthol in traditional Chinese medicine composition
CN101926889B (en) Method for detecting white paeony root-medlar particles
CN102293827A (en) Quality detection method for camphor tree root and preparation containing camphor tree root
CN110108827B (en) Method for simultaneously determining eight active ingredients in antipyretic and antitoxic tablet
CN110988198A (en) Content determination method of bi-tong ning capsules
CN113759057B (en) Characteristic spectrum of allium macrostemon white water extract and preparation thereof and construction method thereof
CN103604898B (en) The benefit heart relaxes the fingerprint atlas detection method of preparation
CN101912522B (en) Detection method of Liuweisheng tablets
CN101028474B (en) Method for inspecting the quality of Chinese preparation with Yang-and kidney tonifying functions

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17759277

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17759277

Country of ref document: EP

Kind code of ref document: A1